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Abstract
Recent technological advances have given cancer researchers the ability to gather vast
amounts of genetic and genomic data from individual patients. These oﬀer tantalizing pos-
sibilities for, for example, basic cancer biology, tailored therapies, and personalized risk
predictions. At the same time, they have also introduced many analytical diﬃculties that
cannot be properly addressed with current statistical procedures, because the number of
genomic covariates in these datasets is often larger than the sample size. In this dissertation
we study methods for addressing this so-called high-dimensional issue when genomic data
are used to analyze time-to-event outcomes, so common to clinical cancer studies.
In Chapter 1, we propose a regularization method for sparse estimation for estimating
equations. Our method can be used even when the number of covariates exceeds the number
of samples, and can be implemented using well-studied algorithms from the non-linear con-
strained optimization literature. Furthermore, for certain estimating equations and certain
regularizers, including the lasso and group lasso, we prove a ﬁnite-sample probability bound
on the accuracy of our estimator.
However, it is well-known that these types of regularization methods can achieve better
performance if a quick and simple procedure is ﬁrst used to reduce the number of covariates.
In Chapter 2, we propose and theoretically justify a principled method for reducing dimen-
sionality in the analysis of censored data by selecting only the important covariates. Our
procedure involves a tuning parameter that has a simple interpretation as the desired false
iiipositive rate of this selection.
Similar types of model-based screening methods have also been proposed, but only for
a few speciﬁc models. Model-free screening methods have also recently been studied, but
can have lower power to detect important covariates. In Chapter 3 we propose a screening
procedure that can be used with any model that can be ﬁt using estimating equations, and
provide uniﬁed results on its ﬁnite-sample screening performance. We thus generalize many
recently proposed model-based and model-free screening procedures. We also propose an
iterative version of our method and show that it is closely related to a recently studied
boosting method for estimating equations.
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11.1 Introduction
With the advent of high-dimensional datasets, sparse estimation has become increasingly im-
portant in regression modeling. However, traditional methods such as stepwise selection have
been found to be unstable (Breiman, 1996), resulting in poor predictive performance. Recent
interest has focused on regularization methods such as the lasso (Tibshirani, 1996), SCAD
(Fan and Li, 2001), or group lasso (Yuan and Lin, 2006), which can perform simultaneous
estimation and variable selection. These procedures have also proved useful in analyzing the
increasingly common high-dimensional data setting, where the number of covariates p can
be larger than the number of subjects n.
Most such procedures are based on regularizing some objective function, such as a likeli-
hood. However, in many cases full likelihood models are diﬃcult to specify, especially with
more complicated data structures such as correlated observations or censored data. In other
situations, such as for robust estimation, it is desirable to model only the ﬁrst or the ﬁrst
few moments of the data instead of the entire likelihood.
For example, in Section 1.3 we study short-term survival in patients with early-stage
non-small-cell lung cancer using SNP data and other clinical covariates. We are interested in
selecting factors that might be associated with the probability of surviving fewer than 3 years,
so that we can preemptively identify higher-risk patients and treat them with more aggressive
therapies. However, we have data on only 100 patients but 74,666 SNPs. Furthermore, we
cannot apply the lasso or SCAD because the model we use to predict 3-year survival does
not ﬁt under the likelihood framework due to our censored outcomes.
In Section 1.3 we also study a multicenter clinical trial of radiation therapy against
two schedules of concurrent chemoradiotherapy for head and neck cancer. Patients on the
standard radiation therapy arm on average do worse than patients on one of the chemoradio-
therapy arms, but also experience signiﬁcantly fewer toxicities. We are interested in selecting
2Table 1.1: A taxonomy of regularization algorithms
Regularizing function
Estimation method ℓ1-type More complex
Objective function Coordinate descent Coordinate descent (convex)
LARS MM algorithms (nonconvex)
Estimating equations Penalized estimating equations Penalized estimating equations
Smooth-thresholding Penalized quadratic form
EEBoost
Penalized quadratic form
factors that might be associated with better survival within patients on the standard arm.
Patients predicted to survive longer then do not need to be treated with the more toxic
therapy. Traditional methods for subgroup analysis often encounter diﬃculties due to mul-
tiple testing (Lagakos, 2006), and these can be alleviated by using a multivariate variable
selection procedure such as the lasso. In this case, several of the factors are categorical and
need to be grouped together when selecting variables, but we cannot use the group lasso
because patient survival times are correlated between centers, making a likelihood diﬃcult
to specify.
In the absence of a likelihood, estimation is often carried out with estimating equations.
There has been a great deal of interest in regularization procedures for estimating equations
that can achieve sparse estimation (see Table 1.1), but some diﬃculties remain. Fu (2003),
Johnson et al. (2008), and Wang et al. (2011) studied penalized estimating equations, but
their proposals can be computationally demanding, or may not yield exactly sparse estimates
(Zhang et al., 2010). Ueki (2009) developed an ℓ1-norm-type regularization methods based
on smooth thresholding, but requires initial n1/2-consistent parameter estimates, which are
diﬃcult to obtain with high-dimensional covariates. Most recently, Wolfson (2011) developed
a boosting algorithm (EEBoost) for estimating equations and showed that this procedure
can produce solutions similar to those from ℓ1-penalized methods, but EEBoost cannot
accommodate more complex regularizing functions, such as the group lasso penalty function.
Finally, none of these papers consider ﬁnite-sample properties of their estimators.
3A popular alternative approach to regularization in the absence of a likelihood is to
penalize an objective function so that the problem is shifted back into the ﬁrst row of
Table 1.1. For example, Wang et al. (2008) regularize the semiparametric AFT model by
penalizing the Buckley-James least-squares loss function. For the semiparametric linear
transformation model, Zhang et al. (2010) proposed constructing a quadratic form from the
estimating equation, using the inverse of an estimate of the estimating equation covariance
matrix. They implemented this penalized quadratic form (PQF) method by using an iterative
procedure, where at each step they penalized a pseudo-least-squares problem derived from
a linear approximation to their quadratic form. In this fashion the PQF can use existing
algorithms to regularize estimating equations using both simple and complex regularizing
functions. However, the covariance matrix can be diﬃcult to estimate and invert, especially
if p is large.
In this paper we propose the nonlinear constrained optimization selector (NCOS), a new
sparse estimation procedure for estimating equations. The method is appealing in that:
1. It requires no initial estimates and can be used with a wide variety of both simple and
complex regularizing functions.
2. For the appropriate regularizing functions, it can perform simultaneous estimation and
variable selection.
3. When the true parameter vector is sparse and the regularizing function is a decom-
posable norm, a concept introduced by Negahban et al. (2009) and reviewed in Sec-
tion 1.5.2, we can give a ﬁnite-sample bound on the ℓ2-error of its estimates for a
certain class of estimating equations.
4. It can be implemented using a variety of well-studied algorithms from the nonlinear
constrained optimization literature.
When the estimating equation is the score equation of the linear model, and when the
4regularizing function is the ℓ1-norm, our NCOS will reduce to the Dantzig selector (Cand` es
and Tao, 2007). In previous work, James and Radchenko (2009), Antoniadis et al. (2010),
and Johnson et al. (2011) studied the Dantzig selector for generalized linear models, the Cox
model, and the AFT model, respectively, but oﬀered no theory applicable to other types of
estimating equations. Dicker (2011) recently extended the Dantzig selector to generalized es-
timating equations and proved asymptotic results, but required a consistent initial estimator
of the regression coeﬃcients. Finally, all of these methods used the ℓ1-norm as a regularizer.
Liu et al. (2009) proposed and theoretically justiﬁed a version of the Dantzig selector with
a group-based regularizer, but their work is limited to the ordinary linear model.
We introduce our NCOS and describe its implementation in Section 1.2, and we apply
it to the non-small-cell lung cancer and head and neck cancer studies in Section 1.3. In
Section 1.4 we study its performance in simulations, and we give our theoretical error bound
in Section 1.5. We conclude with a few remarks in Section 1.6, and leave all proofs for the
Appendix.
1.2 Nonlinear constrained optimization selector
1.2.1 Estimating equations
Let Yi = (Yi1,...,YiKi)T be a Ki ×1 outcome vector and Xi = (Xi1,...,XiKi)T be a Ki ×p
matrix of covariates for units i = 1,...,n, where the Ki are independent and identically
distributed discrete random variables. When Ki = 1 for all i, our formulation reduces to the
usual independent data setting.
Let the p × 1 vector β0 be the true parameter vector, and let U(β) be an estimating
function from Rp to Rp that depends on (Yi,Xi),i = 1,...,n such that E{U(β0)} = 0.
When p < n, β0 is usually estimated by ﬁnding the ˆ β such that U(β) = 0. When p > n,
5however, there are an inﬁnite number of β that can solve U(β) = 0, introducing the need
for a regularizing function r(β) to choose between the diﬀerent possible solutions.
1.2.2 Method
We may consider estimating β0 by choosing the β with the smallest r(β) that also satisﬁes
U(β) = 0. However, requiring U(β) = 0 typically leads to overﬁtting. We instead consider
“almost solving” the estimating equation, or requiring that  U(β) ∞ ≤ γ for some γ > 0.
More speciﬁcally, our NCOS estimate is deﬁned as the ˆ β that solves
minimize r(β) subject to  U(β) ∞ ≤ γ. (1.1)
For example, if γ =  U(0) ∞, then β = 0 is a feasible estimate, and if r(β) reaches a
minimum at 0, ˆ β will be shrunk to 0. The shrinkage parameter γ trades oﬀ between the
bias and variance of ˆ β, and can be chosen using some tuning procedure such as generalized
cross-validation or cross-validation. Note that (1.1) reduces to the Dantzig selector when
r(β) =  β 1 and U(β) is the least-squares score equation.
1.2.3 Implementation
Because r(β) and U(β) can be nonlinear functions, we implement the NCOS using methods
from nonlinear optimization (Leyﬀer and Mahajan, 2010), which gives our proposal its name.
For computational readiness we here employ a sequential linear programming strategy, an
iterative procedure which at each step solves a linear programming subproblem using ap-
proximations to the nonlinear objective and constraint functions. This iterative approach
must be combined with a mechanism for ensuring global convergence, so we implement the
trust region and ﬁlter method of Huang et al. (2011).
6In particular, we ﬁrst deﬁne ˜ β = (β
+,β
−), where β
+
j = max(0,βj) and β
−
j = max(0,−βj)
such that each component of ˜ β is positive. We then deﬁne the functions ˜ r(˜ β) = r(β
+ −β
−)
and ˜ U(˜ β) = U(β
+ − β
−). Finally, we begin with an initial value ˜ β
(0)
= 0 and at each
iteration k solve the subproblem
minimize ˜ r(˜ β
(k)
) + ∇˜ r(˜ β
(k)
)
Td (1.2)
subject to  ˜ U(˜ β
(k)
) −˜ I(˜ β
(k)
)
Td ∞ ≤ γ, d 1 ≤ τ
(k), ˜ βj + dj > 0,j = 1,...,2p, (1.3)
where we optimize over d. Here ˜ I(˜ β) = −∂ ˜ U/∂˜ β and τ(k) is the radius of the “trust region”
in which the linear approximations are deemed appropriate. The solution d(k) gives us a
trial point ˜ β
(k)
+d(k). If this trial point meets certain conditions, it is accepted and ˜ β
(k+1)
is
updated. Otherwise, ˜ β
(k+1)
= ˜ β
(k)
. At the end of each iteration, the size of the trust region is
readjusted; see (Huang et al., 2011), who also prove that this method is globally convergent.
When ˜ r(˜ β) is not continuously diﬀerentiable at 0, we replace ∇˜ r(0) by a subgradient at 0.
Our estimate ˆ β will equal β
+(k) − β
−(k) at convergence.
If the initial value ˜ β
(0)
is too far from the true minimizer, the constraints of the linear
subproblem can be incompatible. To address this we follow the warm starts strategy of
Friedman et al. (2007) and compute NCOS estimates for decreasing values of the tuning
parameter, using the solution for one value of γ as the initial estimate for the next. We let
γmax =  U(0) ∞ and decrease γ on the logarithmic scale to γmin = ǫγmax, where ǫ is small,
for example 10−4.
1.3 Data examples
1.3.1 Non-small-cell lung cancer
Huang et al. (2009) conducted a genome-wide SNP analysis of tumor cells from subjects
with early-stage non-small-cell lung cancer to ﬁnd predictors for overall survival. The study
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Figure 1.1: Overall survival in MGH and Norway datasets
population consisted of n = 100 patients who underwent surgical resection at Massachusetts
General Hospital (MGH). The Kaplan-Meier estimate of the survival curve is displayed in
Figure 1.1. After selecting 74,666 SNPs with ≥ 95% call rate, ≥ 10% subjects with het-
erozygous or variant homozygous alleles, and ≥ 3% subjects with variant homozygous for
analysis, they found ﬁve SNPs whose prognostic signiﬁcance they were able to replicate in
89 similar patients in a validation dataset from the Norwegian National Institute of Occupa-
tional Health (STAMI), whose Kapalan-Meier estimate is also shown in Figure 1.1. They also
measured age, gender, cell type (squamous cell carcinoma or adenocarcinoma), and smoking
history (pack-years), and it is of interest to determine which SNPs or clinical covariates are
associated with surviving less than 3 years, which is close to the 20th percentile of survival
times of the MGH patients. These patients could then be placed on more aggressive or
experimental therapies.
To model this 3-year survival we followed Jung (1996). Let Ti be the survival time, Ci be
the censoring time, Xi = min(Ti,Ci), and δi = I(Ti ≤ Ci) for the ith patient. The number of
risk alleles for the jth SNP is given by Zij, where risk alleles are deﬁned as those associated
8with shorter survival (Huang et al., 2009). We modeled
logit{P(Ti ≥ t0 | Zi)} = β
T
0Zi (1.4)
for t0 equal to 3 years. Let π(η) = logit
−1(η) and π′(η) = ∂π/∂η. To ﬁt the model, Jung
(1996) proposed modifying the logistic regression score equations to handle censored data,
under the assumption that the Ci are independent of Ti and Zi:
U(β) = n
−1
n  
i
Ziπ′(β
TZi)
π(β
TZi){1 − π(β
TZi)}
 
I(Xi ≥ t0)
ˆ SC(t0)
− π(β
TZi)
 
, (1.5)
where ˆ SC(t) is the Kaplan-Meier estimate of the survival function of the censoring time.
With many more covariates than subjects, we followed the recommendation of Fan and Lv
(2008) to preprocess high-dimensional data by screening out a large number of unimportant
covariates before using regularization procedures. This common practice helps to improve
the speed, stability, and accuracy of the regularization. We therefore ﬁrst applied their sure
independence screening method to reduce the number of SNPs to 500. We also included age,
gender, cell type, and smoking history for a total of 504 covariates.
Clearly, (1.5) does not correspond to any likelihood function, but simultaneous estimation
and variable selection can be accomplished with a regularization method for estimating
equations using an ℓ1-norm regularizing function. Given the disadvantages of the penalized
estimating equation and smooth-thresholding procedures discussed in Section 1.1, Table 1.1
suggests that we use the NCOS, the PQF, or EEBoost. We investigated the performances
of all three procedures. Note that the PQF as originally proposed by Zhang et al. (2010)
requires inverting the p × p estimating equation covariance matrix, but this is diﬃcult for
large p. In our implementation we replaced this covariance matrix by the identity matrix,
such that our PQF penalized the squared ℓ2-norm of U(β).
The tuning parameters for these three methods cannot be chosen using AIC or BIC in the
absence of a likelihood. Minimizing the cross-validation estimate of out-of-sample prediction
error is another popular option but can be computationally intensive. Here we followed
9Table 1.2: Covariates associated with 3-year survival in non-small-cell lung cancer (NCOS)
Covariate/SNP Gene
Age (years)
rs2072778 TIPRL: TIP41, TOR signaling pathway regulator-like (S. cerevisiae)
rs13117571 No gene information
rs10739959 No gene information
rs1541871 LSAMP: limbic system-associated membrane protein
rs1514607 No gene information
rs1557689 LHFPL3: lipoma HMGIC fusion partner-like 3
rs11190065 CNNM1: cyclin M1
rs9829162 PDZRN3: PDZ domain containing ring ﬁnger 3
rs6549543 PDZRN3: PDZ domain containing ring ﬁnger 3
rs16884956 No gene information
rs2422705 No gene information
rs2826217 No gene information
rs7832451 No gene information
rs1769792 No gene information
rs17493316 CAMK1D: calcium/calmodulin-dependent protein kinase 1D
rs6989777 NRG1: neuregulin 1
rs17050678 CCRN4L: CCR4 carbon catabolite repression 4-like (S. cerevisiae)
rs978927 ADAMTS3: ADAM metallopeptidase with thrombospondin type 1 motif, 3
rs13219662 No gene information
rs4941229 No gene information
rs6751438 No gene information
rs12822507 CREBL2: cAMP responsive element binding protein-like 2
rs7973428 GPR19: G protein-coupled receptor 19
Johnson et al. (2008) and minimized the simple generalized cross validation-type criterion
  BS/(1−n−1 ˆ β 0)2, where   BS is an estimate of the in-sample Brier score at t0. If ˆ π(t0 | Zi)
is the survival probability at t0, conditional on Zi, of patient i predicted by our ﬁtted model,
the Brier score is deﬁned in (Graf et al., 1999) as
BS = n
−1  
i
 
{0 − ˆ π(t0 | Zi)}2Ni(t0)
ˆ SC(Xi)
+
{1 − ˆ π(t0 | Zi)}2Yi(t0)
ˆ SC(t0)
 
. (1.6)
We used  ˆ β 0, the number of non-zero coeﬃcients of ˆ β, to estimate the degrees of freedom
of the ﬁtted model.
We compared the NCOS, the PQF, and EEBoost by using the models ﬁtted on the
MGH data to produce risk scores for patients in the STAMI dataset, which we then used to
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Figure 1.2: Overall survival in head and neck cancer trial; arm A: radiation therapy, arms
B and C: two schedules of concurrent chemoradiotherapy
calculate the AUC statistic for surviving less than three years (Uno et al., 2007). The NCOS,
the PQF, and EEBoost gave AUC statistics of 0.573, 0.482, and 0.577, respectively. Though
the NCOS and EEBoost performed similarly with respect to prediction, the NCOS produced
the smallest model, selecting 24 covariates. In contrast, the PQF selected 40 covariates and
EEBoost selected 35. Table 1.2 lists the covariates found by NCOS to be predictive of
short-term survival, and interestingly some proteins associated with these SNPs, such as the
ADAM metallopeptidases, are thought to be involved in the molecular biology of non-small-
cell lung cancer (Zhou et al., 2006).
1.3.2 Head and neck cancer
Adelstein et al. (2003) conducted a multicenter randomized clinical trial of radiation therapy
alone (arm A) against two schedules of concurrent chemoradiotherapy (arms B and C) for
patients with nonresectable head and neck cancer. The Kaplan-Meier estimates of the overall
11survival curves are given in Figure 1.2. They found that patients on arm A performed sig-
niﬁcantly worse than patients on arm B, but that the latter group experienced signiﬁcantly
more toxicities. They also collected various patient characteristics, and it is of interest to
determine which can be used to predict the patients on arm A who are likely to see good
results, so that they do not need to receive the more toxic treatment. We considered age,
height, weight, sex, race (white, black or other), ECOG performance status (Oken et al.,
1982), primary tumor site (oral cavity, oropharynx, hypopharnyx, or larynx), tumor diﬀer-
entiation (well-diﬀerentiated, moderately well-diﬀerentiated, or poorly or undiﬀerentiated),
tumor extent (T1 to T3 or T4), nodal status (N0 to N2 or N3), smoking history (pack-years),
and alcohol consumption (ounces per week).
We modeled these data using a marginal Cox model with a working independence cor-
relation structure, following Spiekerman and Lin (1998). The patients on arm A came from
n = 50 diﬀerent institutions, with between 1 and 30 patients per instution for a total of
271 subjects. Let Tik be the survival time, Cik be the censoring time, Xik = min(Tik,Cik),
and δik = I(Tij ≤ Cik) for the kth patient at the ith institution. Also deﬁne Nik(t) =
I(Xik ≤ t,δik = 1) and Yik(t) = I(Xik ≥ t). We modeled the marginal hazard function
for Tik as λ(x;Zik) = λ0(x)exp(β
T
0Zik), where the baseline hazard function is shared across
institutions, and we used the estimating equation
U(β) = n
−1
n  
i=1
Ki  
k=1
   
Zik −
 n
i=1
 Ki
k=1 ZikYik(x)exp(β
TZik)
 n
i=1
 Ki
k=1 Yik(x)exp(β
TZik)
 
dNik(x). (1.7)
Our semiparametric model and correlated outcomes made it diﬃcult to specify a like-
lihood or partial likelihood for (1.7). Furthermore, many of our covariates are categorical,
so we needed to use the group lasso penalty function to eﬀect variable selection. Table 1.1
suggests that we use the NCOS or the PQF. We investigated the performance of both pro-
cedures, where again in our PQF we penalized the squared ℓ2-norm of U(β). We tuned the
NCOS and the PQF to minimize the C-statistic (Uno et al., 2011a) calculated from ﬁve-fold
cross-validation.
12Table 1.3: Covariates associated with overall survival in head and neck cancer
Covariate NCOS PQF
Age (years) 0 0
Height (cm) 0.02 0
Weight (kg) 0 0
Sex (male) -0.48 0
Race (white) 0 0
Race (black) 0 0
Performance status 0.09 0
Tumor site (oral cavity) 0 0
Tumor site (oropharynx) 0 0
Tumor site (hypopharynx) 0 0
Tumor diﬀerentiation (well-diﬀerentiated) 0.41 0
Tumor diﬀerentiation (moderately well-diﬀerentiated) -0.06 0
T4 0 0
N3 0 0
Smoking (pack-years) 0.12 0.07
Alcohol (ounces per week) 0.06 0
We note that in previous work Cai et al. (2005) developed variable selection methodology
speciﬁcally for the marginal multivariate Cox model under the penalized objective function
framework. They applied the SCAD penalty (Fan and Li, 2001) to a pseudo-partial likelihood
and derived asymptotic properties. However, their penalization approach cannot be extended
to arbitrary estimating equations.
To evaluate the predictive ability of the regularization methods, we used ﬁve-fold cross
validation of the data from arm A to estimate the out-of-sample C-statistics of the estimated
models. In each fold we used cross-validation in the training set for tuning. Our NCOS gave
an average C-statistic of 0.64, with a standard deviation of 0.03, while the PQF gave an
average C-statistic of 0.54, with a standard deviation of 0.05. Thus the model produced
by the NCOS provides a better risk classiﬁcation for patients on arm A. We applied both
methods to all patients on arm A, and Table 1.3 gives the resulting parameter estimates.
Note that our NCOS selected the indicator variables corresponding to race, tumor site, and
tumor diﬀerentiation in an all-in or all-out fashion.
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Figure 1.3: Risk classiﬁcations using the NCOS and PQF parameter estimates
As an illustration of the risk discrimination abilities of the models ﬁt using the NCOS and
the PQF, we used the coeﬃcients in Table 1.3 to calculate risk scores for each patient in arm
A. We then dichotomized the patients into those above and below the median risk scores,
and plotted Kaplan-Meier estimates of the resulting risk groups in Figure 1.3. Though these
plots do not represent the out-of-sample predictive ability of the two methods, we can see
that at least in the training data, the NCOS model identiﬁes a subgroup of patients on arm
A who perform better than even the patients on arm B.
1.4 Simulation results
1.4.1 Short-term survival model with ℓ1-norm
In these simulations we studied the regularization of the short-term survival estimating
equation (1.5) with an ℓ1-norm regularizer, as described in Section 1.3.1. We simulated
n = 200 subjects, and for each subject we generated either p = 10 or p = 500 covari-
ates, to mimic low- and high-dimensional cases, from a zero-mean multivariate normal
14Table 1.4: Results for the short-term survival model, p = 10
Method ρ Size FN FP MSE AUC
NCOS 0.5 6.8 (2) 0.15 (0.19) 0.57 (0.26) 0.89 (0.67) 0.75 (0.05)
PQF 0.5 7.11 (2.01) 0.15 (0.19) 0.62 (0.25) 0.91 (0.61) 0.75 (0.05)
EEBoost 0.5 7.14 (1.85) 0.14 (0.17) 0.62 (0.25) 0.9 (0.66) 0.75 (0.05)
NCOS 0.9 4.87 (2.43) 0.41 (0.27) 0.42 (0.29) 2.8 (3.5) 0.66 (0.07)
PQF 0.9 4.42 (2.41) 0.43 (0.26) 0.35 (0.29) 1.99 (1.75) 0.67 (0.07)
EEBoost 0.9 5.47 (2.28) 0.34 (0.25) 0.47 (0.29) 2.9 (3.77) 0.66 (0.06)
with covariate matrix σij = ρ|i−j|, where ρ equaled either 0.5 or 0.9. When p = 10
we let β0 = (−1.1,0.5,0,0,−0.3,0,0,0,0.8,0)T, and when p = 500 we let (β01,...,β010),
(β031,...,β040), and (β061,...,β070) equal the low-dimensional β0, with β0j = 0 for all other
j.
For both the low- and high-dimensional cases we simulated survival data from log(Ti) =
β
T
0Zi + εi with εi having a logistic distribution with mean -0.5 and scale 1. Under this
scheme the model of Jung (1996) is correctly speciﬁed. Finally, we generated Ci from an
independent exponential distribution to give approximately 50% censoring.
We observed that the 20th percentiles of the simulated survival times were roughly t0 = 0.1
when p = 10 and t0 = 0.05 when p = 500, and we used these times when implementing (1.5).
We simulated 200 datasets and calculated the average sizes of the estimated models, the
average false negative (FN) and false positive (FP) rates, and empirical mean squared errors
(MSEs). Finally, to evaluate out-of-sample performance we calculated AUC statistics, using
our ﬁtted models to predict the probability of surviving past t0 in independent test datasets.
We studied the NCOS, the PQF, and EEBoost using an ℓ1 regularizer. To tune the methods,
we used the generalized cross validation-type criterion from Section 1.3.1.
The results are reported in Tables 1.4 and 1.5. In the low-dimensional case, the three
methods appear very similar, though the NCOS selects on average smaller models while
still achieving good MSEs and AUCs. In the high-dimensional case, however, the NCOS
signiﬁcantly outperforms the PQF and EEBoost. When ρ = 0.5, the NCOS selects two-
15Table 1.5: Results for the short-term survival model, p = 500
Method ρ Size FN FP MSE AUC
NCOS 0.5 63.72 (13.58) 0.5 (0.12) 0.12 (0.03) 5.6 (1) 0.67 (0.06)
PQF 0.5 91.9 (7.66) 0.48 (0.12) 0.18 (0.02) 8.08 (1.42) 0.63 (0.06)
EEBoost 0.5 81.3 (11.4) 0.48 (0.12) 0.15 (0.02) 57.12 (13.86) 0.65 (0.07)
NCOS 0.9 28.16 (16.96) 0.81 (0.14) 0.05 (0.03) 6.64 (0.72) 0.59 (0.07)
PQF 0.9 44.23 (26.57) 0.79 (0.16) 0.09 (0.05) 7.43 (1.07) 0.58 (0.07)
EEBoost 0.9 74.66 (11.54) 0.66 (0.13) 0.14 (0.02) 77.22 (18.84) 0.59 (0.07)
thirds as many covariates as the other methods, yet does not have a signiﬁcantly higher FN
rate. Furthermore, its performance in MSE and AUC is comparable to that of the PQF and
better than that of EEBoost. When ρ = 0.9, EEBoost selects large models with high MSEs,
while the NCOS and the PQF look more similar. However, the NCOS now outperforms the
PQF in every category. These results are perhaps because for the ℓ1-norm regularizer, the
sequential linear programming algorithm we use for the NCOS is guaranteed to be globally
convergent (Huang et al., 2011), which is not the case for the PQF. The large MSEs of
EEBoost in high dimensions are surprising, though the performance of EEBoost in this
realm has not yet been well-explored.
1.4.2 Multivariate Cox model with group lasso
In these simulations we studied the regularization of the multivariate Cox model (1.7) with
the group lasso, as described in Section 1.3.2. We simulated data from n = 50 clusters
and let the number of subjects per cluster Ki have a discrete uniform distribution between
1 and 4. For the ith subject in the kth cluster we generated latent variables Vikj, with
j = 1,...,15 or j = 1,...,100 to mimic low- and high-dimensional cases. The Vikj came
from a zero-mean multivariate normal with covariance matrix σij = ρ|i−j|, where ρ equaled
either 0.5 or 0.9. Following Yuan and Lin (2006), we trichotomized each Vikj as 0, 2, or
1 if it was less than Φ−1(1/3), greater than Φ−1(2/3), or in between, respectively, to give
covariate vectors Zik = {I(Vik1 = 0),I(Vik1 = 1),I(Vik2 = 0),I(Vik2 = 1),...}T. In the low-
dimensional case, where p = 30, we let β0 be all zero except for (β01,β02,β05,β06,β09,β010)T =
16Table 1.6: Results for the multivariate Cox model, p = 30
Method ρ Size FN FP MSE C-statistic
NCOS 0.5 12.42 (10.94) 0.27 (0.3) 0.35 (0.4) 5.7 (4.53) 0.74 (0.03)
PQF 0.5 14.86 (10.98) 0.3 (0.31) 0.44 (0.39) 6.36 (6.3) 0.74 (0.03)
NCOS 0.9 11.78 (9.9) 0.26 (0.28) 0.33 (0.36) 6.04 (8.31) 0.74 (0.04)
PQF 0.9 13.58 (8.09) 0.19 (0.26) 0.36 (0.3) 5.4 (6.3) 0.75 (0.04)
(1.2,−1.8,−0.5,−1,−1,−1)T. In high dimensions, where p = 200, we let (β01,...,β030) and
(β031,...,β060) equal the low-dimensional β0, with β0j = 0 for all other j.
We simulated correlated survival data from log(Tik) = β
T
0Zik + εik, and we let εik =
F −1{Φ−1(Nik)}, where F(x) = 1−exp(−ex) is the CDF of the standard Gumbel distribution,
Φ( ) is the standard normal CDF, and (Ni1,...,NiKi) comes from a multivariate normal
with mean zero and covariance matrix σij = 0.5|i−j|. Finally, we generated Cik from an
independent exponential distribution to give approximately 50% censoring.
We applied the NCOS and the PQF to (1.7), and we used the group lasso regularizer,
where the jth group consisted of the variables I(Vij = 0) and I(Vij = 1). We simulated
200 datasets and calculated the average sizes, FN and FP rates, and MSEs. To evaluate
out-of-sample performance we calculated the average C-statistics (Uno et al., 2011a) of the
ﬁtted models in independently simulated test datasets.
To tune the methods, we used the generalized cross validation-type criterion   IBS/(1 −
n−1 ˆ β 0)2 for computational convenience. Here IBS is the integrated Brier score of Graf
et al. (1999). If ˆ π(t | Zi) is the survival probability at time t, conditional on Zi, of patient i
predicted by the ﬁtted Cox model, then the IBS is deﬁned as
IBS =
  t∗
n
−1  
i
 
{0 − ˆ π(t | Zi)}2Ni(t)
ˆ SC(Xi)
+
{1 − ˆ π(t | Zi)}2Yi(t)
ˆ SC(t)
 
dt
t∗, (1.8)
where t∗ = max(Xi) is the largest observed failure time.
The results are reported in Tables 1.6 and 1.7. The methods show the same trends as in
17Table 1.7: Results for the multivariate Cox model, p = 200
Method ρ Size FN FP MSE C-statistic
NCOS 0.5 8.06 (4.78) 0.58 (0.15) 0.02 (0.02) 10.93 (1.68) 0.77 (0.06)
PQF 0.5 10.42 (8.52) 0.72 (0.18) 0.04 (0.04) 12.9 (1.97) 0.7 (0.11)
NCOS 0.9 9.94 (6.22) 0.51 (0.17) 0.03 (0.03) 10.54 (1.34) 0.79 (0.04)
PQF 0.9 16.27 (13.61) 0.64 (0.28) 0.06 (0.06) 12.66 (2.66) 0.69 (0.12)
Section 1.4.1. In almost every case, the NCOS selects smaller models. In the low-dimensional
case the methods look comparable, though the NCOS tends to have slightly higher FN rates
and lower FP rates, which matches our results from Section 1.3.2. In high-dimensions the
NCOS again performs better in nearly every category, especially for ρ = 0.9. In terms of
variable selection, its FN rates are much lower than those of the PQF, and it also has lower
FP rates. Most strikingly, it has lower MSEs and higher C-statistics, with smaller variability
in both statistics.
1.5 Theoretical error bound
We have mentioned that the Dantzig selector can be viewed as a special case of our NCOS.
One appealing feature of the Dantzig selector is that ﬁnite-sample probability bounds on the
ℓ2-error of the estimator can be calculated, and naturally the question arises as to whether
the same can be done for our NCOS.
Unfortunately, we have found it diﬃcult to derive probability bounds for any arbitrary
estimating equation and any arbitrary regularizing function. First, most estimating equa-
tions are nonlinear, so the methods used for deriving the bound on the Dantzig selector do
not immediately apply. Second, bounds of this type require conditions like the restricted
isometry property (RIP) of Cand` es and Tao (2007), which is used to limit the collinearity of
the model. However, in general the collinearity of an estimating equation-based regression
model depends not only on the covariates but also on β, so that any RIP-type conditions
18must depend on β as well. Finally, the special properties of the ℓ1 penalty function that are
necessary for stating these bounds are not necessarily shared by arbitrary r(β).
However, we will be able to give an exact ﬁnite-sample probability bound on the size of
 ˆ β − β0 2 for a certain class of estimating equations and a certain class of r(β). This class
of estimating equations includes some important cases, and the class of r(β) includes the
commonly used lasso and group lasso penalties.
1.5.1 Assumptions on U(β)
Assumption 1 The estimating equation U(β0) can be written as n−1  n
i=1 ψi(β0;Yi,Xi)
for p × 1 vector-valued functions ψi that depend on Yi and Xi.
Assumption 2 The ψi(β0;Yi,Xi) have mean 0, and for the jth component ψij(β0;Yi,Xi)
there exist constants M and v such that E|ψij(β0;Yi,Xi)|m ≤ m!Mm−2v/2 for m ≥ 2 and
for all j.
Assumption 1 states that U(β) is a sum of independent and identically distributed terms.
Assumption 2 bounds the moments of those terms, and can usually be satisﬁed by assuming
bounded covariates. While Assumption 1 is somewhat restrictive, it holds for a number of
important estimating equations, such as generalized estimating equations (Liang and Zeger,
1986). These assumptions allow us to invoke Bernstein’s inequality, but for certain U(β) they
can be relaxed. For example, Bernstein-type inequalities exist for U-statistics (Hoeﬀding,
1963) and martingales (van de Geer, 1995).
We must also assume that U(β) satisﬁes something similar to the restricted isometry
property (RIP) of Cand` es and Tao (2007). We will call a vector c is k-sparse if at most k
of its components are nonzero. An arbitrary n × p matrix A has the RIP if there exists a
19restricted isometry constant δk and a restricted orthogonality constant θk,k′ such that
 
1 − δK c 2 ≤  Ac 2 ≤
 
1 + δk c 2 and |c
TA
TAc
′| ≤ θk,k′ c 2 c
′ 2 (1.9)
for all k-sparse p × 1 vectors c and k′-sparse p × 1 vectors c′, where c and c′ have disjoint
supports. In the linear regression setting, a ﬁnite-sample error bound for the Dantzig selector
was derived by assuming that the design matrix had the RIP, which amounts to assuming
that the observed covariate vectors are not too collinear.
In the estimation equation setting, however, collinearity depends not only on the design
matrix but also varies across the parameter space (Mackinnon and Puterman, 1989; Lesaﬀre
and Marx, 1993), such that a model may be collinear even if its design matrix is not. Thus
to derive a ﬁnite-sample bound for our NCOS, we assume that the conditions of the RIP
hold across the entire parameter space Θ.
Assumption 3 The estimating equation U(β) is diﬀerentiable with respect to β. Let the
negative Jacobian −∂U/∂β be denoted A(β).
Assumption 4 There exist constants δk > 0 and θk,k′ such that for all k-sparse c and
k′-sparse c′ with disjoint supports,
δk c 
2
2 ≤ |c
TA(β)c| and |c
TA(β)c
′| ≤ θk,k′ c 2 c
′ 2 (1.10)
for all β ∈ Θ.
When U(β) is the score function of a likelihood, A(β) from Assumption 3 is the observed
information matrix evaluated at β. Assumption 4 is similar to the RIP. The ﬁrst part of
Assumption 4 requires that each k ×k submatrix of A(β) be invertible. If θk,k′ is small, the
second part of Assumption 4 roughly requires that each k∗ × k∗ submatrix act like a scalar
multiple of an identity matrix, where k∗ = max(k,k′). If Θ is unbounded, it is not clear
20that δk and θk,k′ will be ﬁnite. In the case of linear regression, A(β) is in fact independent
of β, so that the RIP constants are ﬁnite over Θ = Rp. In general, however, since we do not
expect the components of β to be arbitrarily large, we could assume that Θ is bounded.
1.5.2 Decomposable norm-based regularizing functions
We will consider regularizers r(β) that are norms and that are decomposable, a concept
introduced by Negahban et al. (2009). Decomposability is deﬁned relative to a subspace
of A of Rp, which is termed the model subspace and represents information about β0. For
example, it may be the subspace of vectors deﬁned by the non-zero coordinates of β0. Its
orthogonal complement A⊥ is termed the perturbation subspace and represents deviations
away from β0. We decompose any β into its projections onto the model and perturbation
subspaces, which we will denote x and y, such that β = x + y.
Negahban et al. (2009) deﬁned r(β) to be decomposable with respect to A if
r(x + y) = r(x) + r(y) for all x ∈ A,y ∈ A
⊥. (1.11)
To understand the intuitive rationale behind this property, consider that we would like to
minimize r(y), the norm of the components of β in the perturbation subspace. However, we
generally do not know which components of β are in A⊥, so we can only minimize the norm
of the entire vector β. But because r is a norm, r(β) ≤ r(x)+r(y), so minimizing r(β) will
not necessarily minimize r(y) unless we have equality. This is exactly what is required by
decomposability. Note that when we minimize a decomposable r(β), we minimize r(x) in
addition to r(y), so that our estimates for the components of β0 in the model subspace will
be biased toward zero.
It turns out that many useful regularizing functions satisfy decomposability. If r(β) is
the ℓ1-norm, then consider T0 = {j : β0j  = 0} and A0 = {x ∈ Rp : xj  = 0 for j ∈ T0}.
It is clear that the ℓ1-norm is decomposable with respect to A0. Next, suppose β0 obeys
21some group structure, and let T0 be such that T c
0 contains the indices corresponding to the
unimportant groups. If A0 = {x ∈ Rp : xj = 0 for j / ∈ T0}, then the group lasso penalty,
which is a sum of ℓ2-norms and is therefore a norm, is decomposable with respect to A0.
In addition, it is easy to see that the adaptive versions of these regularizers, where each
component of β is divided by a consistent initial estimator, are also decomposable norms.
More details are given in Negahban et al. (2009).
1.5.3 Error bound
With these assumptions on U(β) and r(β), we can state a ﬁnite-sample bound on the error of
our NCOS estimator. We ﬁrst deﬁne a few terms. With A0 and T0 deﬁned as in Section 1.5.2,
consider a regularizing function r(β) that is a decomposable norm with respect to A0, and
let |To| = k. To bound the ℓ2-norm of ˆ β − β0, we will need to link the regularizing norm to
the ℓ2-norm. To this end we use the concept of subspace compatibility constants, introduced
by Negahban et al. (2009), which is related to the topological concept of equivalent norms.
Let Ψ12(A0), Ψ, and Ψr2(A0) be three subspace compatibility constants, which are deﬁned
in greater detail in Appendices 1.7.1 and 1.7.2.
Theorem 1 Let U(β) be an estimating function satisfying Assumptions 1–4, and assume
that β0 is k-sparse. If
c1 = δ1.25k − θk,1.25kΨ12(A0)
−1ΨΨr2(A0) > 0, (1.12)
then the NCOS estimate ˆ β obtained by solving (1.1) obeys
P
 
 ˆ β − β0 2 ≤
(10k)1/2γ
c1
 
≥ 1 − 2pexp
 
−
nγ2
2(v + Mγ)
 
, (1.13)
where γ > 0 is nonrandom tuning parameter and v and M are positive constants deﬁned in
Assumption 2.
22For any n and p, Theorem 1 gives an upper bound for the mean squared error of ˆ β that holds
with high probability. The requirement that β0 be sparse is common in high-dimensional
data analysis, and without it, it is very diﬃcult to get useful bounds on estimation error.
The size of our bound depends on the subspace compatibility constants, and when r(β) is
the ℓ1-norm or the group lasso penalty, Negahban et al. (2009) showed that the Ψ terms are
ﬁnite. Theorem 1 is similar to the error bounds of the Dantzig selector in the linear model
(Cand` es and Tao, 2007) and the Cox model (Antoniadis et al., 2010). In those cases, the
estimator is capable of achieving, with high probability, a rate of convergence within a factor
of logp of the optimal rate that an oracle estimator would provide.
The condition on c1 roughly requires that every submatrix of A(β) with at most 1.25k
columns be approximately invertible and orthogonal for all β ∈ Θ. Similar assumptions
were made by Cand` es and Tao (2007), Antoniadis et al. (2010), and Cai et al. (2010).
In particular, if r(β) is the ℓ1-norm, then Ψ12(A0)−1ΨΨr2(A0) = 1 (see Appendix) and
our condition on c1 reduces to δ1.25k > θk,1.25k, which is weaker than the corresponding
conditions of Cand` es and Tao (2007) and Antoniadis et al. (2010). If r(β) is the group lasso
regularizer, then Ψ12(A0)−1ΨΨr2(A0) equals the square root of the number of groups with
nonzero components, multiplied by the maximum group size, divided by k. This is again
close to 1 if groups have roughly the same size.
1.6 Discussion
In this paper we have proposed a new sparse estimation procedure for estimating equations.
We have shown that the NCOS can give good results in real data and in simulations, per-
forming simultaneous estimation and variable selection with lasso and group lasso penalties
for two diﬀerent estimating equations. Our implementation of the NCOS, using a sequential
linear programming strategy with a trust region and a ﬁlter, also enjoys global convergence
properties (Huang et al., 2011). Finally, for decomposable norm-based regularizers, which
23include the lasso and the group lasso, we have provided a probability bound on the ℓ2-error
of the NCOS parameter estimates.
While our Theorem 1 applies only to a certain class of estimating equations and a certain
class of regularizers, the NCOS algorithm itself does not require these restrictions. In fact, our
sequential linear programming implementation can be used with a wide variety of estimating
equations and r(β), including nonconvex r(β) such as SCAD (Fan and Li, 2001) or the group
bridge penalty for between- and within-group selection (Huang et al., 2009; Wang et al.,
2009). While it is diﬃcult to derive ﬁnite-sample error bounds for these r(β), it would be
interesting to investigate their asymptotic properties, along the lines of Dicker (2011).
In this work we have focused on smooth estimating equations, but in some cases U(β)
may not be diﬀerentiable. In this situation the implementation of the NCOS would require
a diﬀerent algorithm, such as derivative-free constrained optimization (Conn et al., 2009).
So far, however, these methods are limited in the number of variables they can reasonably
accommodate. Nevertheless, we believe that our NCOS is a ﬂexible and useful strategy for
regularizing estimating equations.
1.7 Appendix A: Proof of Theorem 1
1.7.1 Subspace compatibility constant
We will need to deﬁne the subspace compatibility constant, introduced by Negahban et al.
(2009). For any pair of norms a and b and subspace A, the subspace compatibility constant
is
Ψab(A) = inf{c > 0|a(u) ≤ cb(u) for all u ∈ A}, (1.14)
and is a measure of how similar the norms a and b are over the subset A. Below, we will
denote the ℓ1-, ℓ2-, and r- norms by replacing a or b in Ψab with 1, 2, or r. For example, if
24A has dimension k, then Ψ12(A) = k1/2.
1.7.2 Proof
Recall the set of indices T0 from Section 1.5.2. Let h be the vector constructed by arranging
the components of ˆ β − β in decreasing order of magnitude after placing the elements of
T0 ﬁrst, and assume that the entries of U(β) and A(β) are reordered accordingly. Relabel
T0 = {1,...,k}, and let T∗ = {k + 1,...,5k/4}, and Ti,i ≥ 1 be successive subsets, each
of size k, of the remaining indices {5k/4 + 1,...,p}. If k < 4, then T∗ = {k + 1}, and the
last Ti can contain fewer than k elements. For sets T1 and T2, let cT1 denote the subvector
of c consisting of the components indexed by T1, and XT1,T2 denotes the submatrix of X
consisting of the rows indexed by T1 and the columns indexed by T2. Let XT1,  denote
the submatrix with rows indexed by T1 and containing all p columns. Finally, redeﬁne the
subspace A0 as in Section 1.5.2 and deﬁne A∗ and Ai analogously.
We ﬁrst note that by the fundamental theorem of calculus, for the jth component Uj of
U,
Uj(ˆ β) − Uj(β0) = −
  1
0
p  
l=1
Ajl(β0 + th)hldt, (1.15)
where Ajl is the jlth element of the negative Jacobian A and hl is the lth component of h.
Deﬁne D to be the p × p matrix where the jlth element
Djl =
  1
0
Ajl(β0 + th)dt. (1.16)
First, by the Cauchy-Schwarz inequality,
   h
T
T0∪T∗DT0∪T∗, h
    ≤  hT0∪T∗ 2 DT0∪T∗, h  (1.17)
=  hT0∪T∗ 2 U(ˆ β)T0∪T∗ − U(β0)T0∪T∗ 2. (1.18)
By the deﬁnition of the NCOS optimization problem (1.1),  U(ˆ β) ∞ ≤ γ. We will also later
25show that  U(β0) ∞ ≤ γ with high probability. We can therefore conclude that
   h
T
T0∪T∗DT0∪T∗, h
    ≤  hT0∪T∗ 2(1.25k)
1/22γ. (1.19)
Now, note that for any k-sparse vector c,
|c
TDc| =
         
  1
0
 
jl
cjAjl(β0 + th)cldt
         
≥
       
  1
0
δk c 
2
2dt
        = δk c 
2
2, (1.20)
because by Assumption 4 the restricted isometry constant δk of A(β) holds for all β ∈ Θ.
Similarly, for any k′-sparse c′ where c and c′ have disjoint support, we ﬁnd that
|c
TDc
′| ≤ θk,k′ c 2 c
′ 2. (1.21)
Therefore,
   h
T
T0∪T∗DT0∪T∗, h
    =
         
h
T
T0∪T∗DT0∪T∗,T0∪T∗hT0∪T∗ +
 
i≥1
h
T
T0∪T∗DT0∪T∗,TihTi
         
(1.22)
≥
   h
T
T0∪T∗DT0∪T∗,T0∪T∗hT0∪T∗
    −
 
i≥1
   h
T
T0∪T∗DT0∪T∗,TihTi
    (1.23)
≥ δ1.25k hT0∪T∗ 
2
2 −
 
i≥1
θk,1.25k hT0∪T∗ 2 hTi 2. (1.24)
We focus on the
 
i≥1  hTi 2. If we denote the ﬁrst k/4 elements of Ti by Ti1 and the
last 3k/4 elements by Ti2, and deﬁne the subspaces Ai1 and Ai2 accordingly, then using the
shifting inequality of Cai et al. (2010) we can show that
 hT1 2 ≤ k
−1/2 ( hT∗ 1 +  hT11 1) (1.25)
≤ Ψ12(A0)
−1 {Ψ1r(A∗)r(hT∗) + Ψ1r(A11)r(hT11)}, (1.26)
 hTi 2 ≤ k
−1/2
 
 hT(i−1)2 1 +  hTi1 1
 
(1.27)
≤ Ψ12(A0)
−1
 
Ψ1r(A(i−1)2)r(hT(i−1)2) + Ψ1r(Ai1)r(hTi1)
 
,i = 2,3,... (1.28)
Then we can conclude that
 
i≥1  hTi 2 ≤ Ψ12(A0)−1Ψr(hTc
0), where
Ψ = max{Ψ1r(A∗),Ψ1r(Ai1),Ψ1r(Ai2),i = 1,2,...}. (1.29)
26Next, by the deﬁnition of our optimization problem, if β0 is feasible then we must have
that r(β0) ≥ r(ˆ β) (we will show later that β0 is indeed feasible with high probability).
Also, by assumption r(β) is decomposable with respect to A0, so r(ˆ β) = r(ˆ βT0) + r(ˆ βTc
0).
Combining these facts and using the triangle inequality, we ﬁnd that r(β0) ≥ r(β0T0) −
r(hT0) + r(ˆ βTc
0). Since β0T0 = β0 and β0Tc
0 = 0, we see that r(hT0) ≥ r(ˆ βTc
0) = r(ˆ βTc
0 −
β0Tc
0) = r(hTc
0).
We can therefore conclude that
 
i≥1
 hTi 2 ≤ Ψ12(A0)
−1Ψr(hT0) ≤ Ψ12(A0)
−1ΨΨr2(A0) hT0 2 (1.30)
≤ Ψ12(A0)
−1ΨΨr2(A0) hT0∪T∗ 2. (1.31)
By the triangle inequality,  hTc
0 2 ≤
 
i≥1  hTi 2, so
   h
T
T0∪T∗DT0∪T∗, h
    ≥
 
δ1.25k − θk,1.25kΨ12(A0)
−1ΨΨr2(A0)
 
 hT0∪T∗ 
2
2. (1.32)
Because  h 2
2 =  hT0∪Ti 2
2+
 
i≥1  hTi 2
2 ≤  hT0∪Ti 2
2+(
 
i≥1  hTi 2)2 ≤ 2 hT0∪Ti 2
2, we can
combine (1.19) and (1.32) to ﬁnd that  ˆ β − β0 2 ≤ (10k)1/2γ/c1.
Finally, we show that  U(β0)  ≤ γ with high probability, which implies that β0 is
feasible. But by Assumptions 1 and 2 and Bernstein’s inequality,
P( U(β0) ∞ ≥ γ) ≤ 2pexp
 
−
n2γ2
2(nv + Mnγ)
 
, (1.33)
and we have proven Theorem 1.
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282.1 Introduction
An urgent need has emerged in the ﬁeld of biomedicine for statistical procedures capable
of analyzing and interpreting vast quantities of data. Selecting the best predictors of an
outcome is a key step in this process, but traditional methods of variable selection, such as
best subset selection or backward selection, have been found to be unstable and inaccurate
when the dimension of the covariates is close to the number of observations. Furthermore,
when there are more covariates than observations, as is often the case in genomic studies,
these methods can fail completely.
To address these issues, recent work has focused on regularized regression procedures
such as the lasso (Tibshirani, 1996) and adaptive lasso (Zou, 2006), the elastic net (Zou and
Hastie, 2005), the smoothly clipped absolute deviation estimator (Fan and Li, 2001), and the
Dantzig selector (Cand` es and Tao, 2007). These methods can handle the high-dimension-
low-sample-size paradigm, have superior predictive accuracy, and under certain conditions
can achieve the oracle property (Fan and Li, 2001): they are as accurate and eﬃcient as an
estimator that knows a priori which variables are truly important.
However, these procedures only work well with a moderate number of covariates. When
the dimension of the covariates is ultra-high, both traditional and regularization methods
have problems with speed, stability, and accuracy (Fan and Lv, 2008). For example, many
of the bounds on the accuracy of these methods involve factors of logpn, where pn is the
dimension of the covariates (Cand` es and Tao, 2007; Wainwright, 2009). Thus the theoret-
ical performance of these methods degrades as pn becomes very large, yet this ultra-high
dimensionality characterizes many real-world biological datasets. Our work in this paper is
motivated by one such dataset, in the area of multiple myeloma.
Multiple myeloma is the world’s second-most common hematological cancer and patients
often present with bone lesions, immunological disorders, and renal failure. An eﬀective
29treatment is still being sought, as only about 10% of patients survive 10 years after diag-
nosis. A deeper understanding of the molecular etiology of this disease would lead to novel
therapeutic targets and more accurate risk classiﬁcation systems. We studied overall survival
for 80 multiple myeloma patients enrolled in a clinical trial of bortezomib (Mulligan et al.,
2007). With expression level measurements on 44760 probesets, this dataset deﬁes analysis
even with regularized regression.
Without tools to deal with this type of ultra-high dimensionality, many analysts employ
an initial univariate screening step to reduce the number of covariates under consideration.
The remaining covariates could then be fed to one of the more sophisticated regulariza-
tion techniques in a second stage. But it was only recently that Fan and Lv (2008) placed
this ad-hoc practice on ﬁrm theoretical ground, showing that that screening could indeed
improve the performance of regularization methods. They suggested ﬁtting marginal re-
gression models for each covariate, choosing a threshold, and retaining those covariates for
which the magnitudes of the parameter estimates are above the threshold. When the data
come from an ordinary linear model with normal errors, Fan and Lv (2008) showed that this
pre-screening procedure, which they termed sure independence screening (SIS), has desirable
theoretical properties. Fan and Song (2010) later gave theoretical justiﬁcation for using SIS
with generalized linear models.
But two important problems remain. First, one common type of outcome data seen
in clinical settings, including in our myeloma dataset, is survival time, which is subject to
censoring. Regularized regression methods for censored observations have been studied, as
reviewed in Li (2008), but these are subject to the same issues mentioned above when the
dimension of the covariates is ultra-high. There is thus a need for a pre-screening procedure
in this setting, but the results of Fan and Lv (2008) and Fan and Song (2010) cannot
be applied because the issue of censoring is not addressed. Several ad-hoc solutions are
available from Tibshirani (2009) and Fan et al. (2010), but none of these proposals has much
theoretical support. The extension of the theoretical sure screening results to censored data
is not immediate because it turns out that certain conditions on the relationship between the
30covariates and the censoring distribution are required for screening to have good theoretical
properties, an issue which does not emerge with uncensored data.
The second problem is that existing screening procedures require choosing a threshold
to dictate how many variables to retain, but there are no principled methods for making
such a choice, making the resulting screened models diﬃcult to evaluate. The threshold can
be thought of as a regularization parameter, which in the regression setting is ordinarily
chosen by optimizing out-of-sample prediction error using cross-validation or generalized
cross-validation. However, this approach is unavailable for screening procedures because no
prediction rule is ever generated.
In this paper we provide a screening method for censored survival data with ultra-high-
dimensional covariates. We also propose a new, principled method for choosing the number of
covariates to retain based on specifying the desired false positive rate. Finally, we give, to our
knowledge, the ﬁrst theoretical justiﬁcations of the sure independence screening procedure
for censored data. Under the asymptotic framework where the number of covariates can
grow with the sample size, we show that with probability going to 1, our procedure will
select all of the important variables with a false positive rate close to the prespeciﬁed level.
Our paper is organized as follows. We brieﬂy review sure independence screening for
generalized linear models in Section 2.2. In Section 2.3 we discuss the implementation and the
theoretical properties of our principled sure independence screening procedure, and present
simulation results in Section 2.4. Section 2.5 describes our analysis of the myeloma dataset,
and we conclude with a discussion in Section 2.6. All proofs are given in the Appendix.
312.2 Sure independence screening in generalized linear
models
We ﬁrst review the sure independence screening formulation of Fan and Song (2010). For
subjects i = 1,...,n let Zi = (Zi1,...,Zipn) be the pn-dimensional covariate vector. As-
suming that observations Yi come from an exponential family, we model E(Yi | Zi) as some
function of a linear predictor αT
0Zi with parameter vector α0 = (α01,...,α0pn). When pn
is much larger than n we are unable to estimate α0 with conventional procedures. To re-
duce pn, sure independence screening proceeds by regressing Yi on each Zij individually to
calculate marginal maximum likelihood estimates ˆ βj. The ﬁnal screened model retains all
covariates j : |ˆ βj| ≥ γn for some prespeciﬁed constant cutoﬀ γn.
Fan and Song (2010) showed that under certain conditions, if γn follows an ideal rate,
this procedure has two desirable properties, namely the sure screening property and the size
control property. The former guarantees that the screened model will contain the true model
with a probability approaching 1. The latter states that if log(pn) = o(n1−2κ) where κ < 1/2,
the probability that the size of the screened model will be at most O{n2κλmax(Σ)} will also
go to 1, where Σ = var(Zi) and λmax(Σ) is the largest eigenvalue of Σ.
These results, however, are restricted to non-censored generalized linear models. Further-
more, it is diﬃcult to translate the ideal rate for γn into a method for selecting the cutoﬀ in
practice. Fan and Lv (2008) suggest n/log(n) or n−1 as the number of covariates to retain
after screening, but without theoretical justiﬁcation. To address these issues, we investigate
here a reliable pre-screening procedure in a survival setting, where the outcomes are subject
to right censoring, and propose a principled method for choosing γn based on controlling the
false positive rate.
322.3 Principled Cox sure independence screening
2.3.1 Method
In the context of survival analysis, we assume that the underlying survival times Ti follow a
Cox model (Cox, 1972) with the true hazard function
λ(x;Zi) = λ0(x)exp(α
T
0Zi), (2.1)
where λ0(x) is unspeciﬁed. Let ˜ Ci be potential censoring times, which are independent
of Ti conditional on Zi. Furthermore let τ > 0 be the ﬁnite study duration such that
P{min( ˜ Ci,τ) < Ti} < 1, ensuring that enough events will be observed over [0,τ]. The
eﬀective censoring times are thus Ci = min( ˜ Ci,τ). We observe Xi = min(Ti,Ci), and
δi = I(Ti ≤ Ci). Without loss of generality, we assume throughout that E(Zij) = 0 for all j.
To perform an initial screening procedure, we propose to ﬁt marginal Cox regressions,
possibly misspeciﬁed, for each Zij, namely λ∗
0(x)exp(βZij). Let Ni(t) = I(Xi ≤ t,δi = 1)
be independent counting processes for each subject i and Yi(t) = I(Xi ≥ t) be the at-risk
processes. For k = 0,1,..., deﬁne
S
(k)
j (x) = n
−1
n  
i=1
Z
k
ijYi(x)λ(x;Zi), s
(k)
j (x) = E{S
(k)(x)}, (2.2)
S
(k)
j (β,x) = n
−1
n  
i=1
Z
k
ijYi(x)exp(βZij), s
(k)
j (β,x) = E{S
(k)(β,x)}. (2.3)
Then the maximum marginal partial likelihood estimator ˆ βj solves the estimating equation
Uj(β) =
n  
i=1
  τ
0
 
Zij −
S
(1)
j (β,x)
S
(0)
j (β,x)
 
dNi(x) = 0. (2.4)
Finally, let β0j be the solution to the limiting estimation equation
uj(β) =
  τ
0
 
s
(1)
j (x) −
s
(1)
j (β,x)
s
(0)
j (β,x)
s
(0)
j (x)
 
dx. (2.5)
33Deﬁne the information matrix to be Ij(β) = −∂Uj/∂β at ˆ βj. We will denote the ﬁnal
screened model by ˆ M = {j : Ij(ˆ βj)1/2|ˆ βj| ≥ γn}. We would like a practical way of choosing
γn such that we can achieve the sure screening property while controlling the false positive
rate, or the proportion of unimportant covariates we incorrectly include in ˆ M. If the true
model M = {j : α0j  = 0} has size |M| = sn, then the expected false positive rate can be
written as
E


      ˆ M ∩ Mc
     
|Mc|

 =
1
pn − sn
 
j∈Mc
P
 
Ij(ˆ βj)
1/2|ˆ βj| ≥ γn
 
. (2.6)
We can show that Ij(ˆ βj)1/2ˆ βj has an asymptotically standard normal distribution, so we see
that γn corresponds to controlling the expected false positive rate at 2{1 − Φ(γn)}, where
Φ( ) is the standard normal cumulative distribution function.
However, we would like the false positive rate to decrease to 0 as pn increases with n,
though it can never exactly equal 0 or else γn = ∞. One sensible way to do this would be to
ﬁrst ﬁx the number of false positives f that we are willing to tolerate, which would correspond
to a false positive rate of f/(pn − sn). Because sn is unknown, we can be conservative by
letting γn = Φ−1{1 − qn/2)} where qn = f/pn, so that the expected false positive rate is
2{1 − Φ(γn)} = qn ≤ f/(pn − sn). We can show that this procedure maintains the sure
screening property, and more precise arguments will be given later (Theorems 5 and 6).
We term this method a principled Cox sure independence screening procedure (abbrevi-
ated PSIS), as the cutoﬀ γn is selected to control the false positive rate. Speciﬁcally, PSIS
is implemented as follows:
1. Fit a marginal Cox model for each of the covariates according to equation (2.4) to get
parameter estimates ˆ βj and variance estimates Ij(ˆ βj)−1.
2. Fix the false positive rate qn = f/pn and let γn = Φ−1(1 − qn/2).
3. Retain covariates j : Ij(ˆ βj)1/2|ˆ βj| ≥ γn.
34Our cutoﬀ selection procedure is related to false discovery rate (FDR) methods (Ben-
jamini and Hochberg, 1995; Benjamini and Yekutieli, 2001). In particular, the FDR is
deﬁned as | ˆ M ∩ Mc|/| ˆ M|, which is simply the product of the false positive rate in (2.6)
and |Mc|/| ˆ M|, which is less than pn/| ˆ M|. Therefore, controlling the false positive rate at
qn = f/pn is equivalent to controlling the FDR at f/| ˆ M|, conditional on | ˆ M|. Bunea et al.
(2006) have in fact shown that FDR methods can also have the sure screening property,
though only in the linear regression case.
Our screening procedure resembles the “marginal ranking” methods for censored outcome
data proposed by various authors (Fan et al., 2010; Tibshirani, 2009). However, to our
knowledge, none of these proposals has much theoretical support. A much more aggressive
method of control has been proposed by Fan et al. (2010). We show below that our proposed
procedure maintains the sure screening property, and will also control the false positive rate
at close to the nominal level. Fan and Lv (2008) also proposed an iterative sure independence
screening procedure (ISIS) for linear models, which they showed can perform better than
SIS. However, they were unable to oﬀer theoretical support. In this paper we focus on ﬁrst
understanding non-iterative screening for the Cox model.
2.3.2 Theoretical properties
First, under certain assumptions, we ﬁnd that we can distinguish α0j, j ∈ M from α0j,
j ∈ Mc in the presence of censoring. It is this guarantee that makes the marginal screening
approach possible.
Theorem 2 Under Assumptions 5–12 in the Appendix, β0j = 0 if and only if α0j = 0, for
all j = 1,...,pn.
35Following Struthers and Kalbﬂeisch (1986) and under Assumptions 5 and 6 in the Ap-
pendix, we know that the ˆ βj are consistent for β0j. It is therefore natural to ask how accurate
these estimates are.
Theorem 3 Under Assumptions 5–12 in the Appendix,
P
 √
n|ˆ βj − β0j| ≥ 4K[1 + Λ0(τ)exp{2K(A + L)}](1 + t)/H
 
≤ exp(−t
2/2) (2.7)
for all j = 1,...,pn, where K is the bound on the covariates Zij for all j, Λ0(τ) =
  τ
0 λ0(s)ds
is bounded by Assumption 8, A is the bound on the parameters α0j for all j, L =  α0 1 and
is bounded by Assumption 7, and H is deﬁned in Assumption 9.
Theorem 3 is important as it suggests that |ˆ βj − β0j| is at most on the order of n−1/2
with high probability. Hence in order to detect covariate j ∈ M, we need |β0j| to be at least
O(n−1/2), which is indeed the case as shown by the following theorem.
Theorem 4 Under Assumptions 5–12 in the Appendix, there is a constant c2 > 0 such that
minj∈M |β0j| ≥ c2n−κ, where κ < 1/2.
Because the |β0j| are large enough to be detected with our marginal Cox regressions, and
because they reﬂect the importance of the Zij in the true joint model, we can prove that our
procedure maintains the sure screening property and controls the false positive rate at close
to the nominal level.
Theorem 5 (Sure screening property) Under Assumptions 5–12 in the Appendix, if we
choose γn = Φ−1(1−qn/2), then for κ < 1/2 and log(pn) = O(n1/2−κ), there exists a constant
c3 > 0 such that
P(M ⊆ ˆ M) ≥ 1 − sn exp(−c3n
1−2κ). (2.8)
36Theorem 6 (False positive control property) Under Assumptions 5–12 in the Ap-
pendix, if we choose γn = Φ−1(1 − qn/2), then there exists some c4 > 0 such that
E
 
| ˆ M ∩ Mc|
|Mc|
 
≤ qn + c4n
−1/2, (2.9)
where | ˆ M ∩ Mc|/|Mc| can be interpreted as the false positive rate.
It is often assumed that the true model is sparse and sn is small (Cand` es and Tao, 2007),
in which case Theorem 5 indicates that we will be able to retain all important covariates with
high probability. The probability bound will converge to 1 if log(pn) = O(n1/2−κ), which is
comparable to the rates allowed in Fan and Lv (2008) and Fan and Song (2010). That pn is
allowed to incease exponentially justiﬁes the use of sure independence screening in the Cox
model when pn is ultra-high-dimensional.
2.4 Simulations
To evaluate the ﬁnite-sample performance of our sure screening and false positive control
properties, we performed PSIS on simulated datasets generated from Cox models and exam-
ined its average false positive and negative rates. We simulated 200 datasets, each consisting
of pn = 20000 covariates and n = 100 subjects. We generated the covariates from a multi-
variate normal distribution where the mean was 0 and the correlation between components
Zij and Zik was ρ|j−k| for ρ = 0.5, and 0.9. We next generated survival times from Cox
models with baseline hazards of λ0(x) = 1 and linear predictors αT
0Zi for diﬀerent parame-
ter vectors α0. We let the number of non-zero elements of α0 be either sn = 10 or 20 and
set the ﬁrst sn components of α0 to be either all equal to 0.35 or all equal to 0.7. Finally,
we generated censoring times from a uniform and an exponential distribution, which gave
bounded and unbounded censoring times respectively. Under each censoring mechanism, we
considered censoring rates of approximately 20%, 50%, and 70%.
37To explore how the variable selection performance of a few popular regularized regression
techniques were aﬀected by PSIS with diﬀerent values of qn, we followed PSIS by either lasso
(Tibshirani, 1997), adaptive lasso (Zhang and Lu, 2007), or SCAD (Fan and Li, 2002).
Since the initial parameter estimates required by adaptive lasso do not exist when pn > n,
we ﬁrst applied ordinary lasso to reduce pn and calculated the initial estimates using the
remaining covariates. We implemented lasso and adaptive lasso using a coordinate descent
algorithm (Friedman et al., 2007) with the R package glmnet, and we implemented SCAD
using the one-step estimator of Zou and Li (2008) with the package SIS. We tuned each
regularized regression with BIC to achieve selection consistency, and we denote these two-
stage procedures by PSIS-L, PSIS-L-A, and PSIS-S, respectively.
Tables 2.1 and 2.2 report numerical results for our sure screening and false positive
control properties when sn = 20, α0j = 0.35, and when censoring times were generated from
an exponential distribution. The results when sn = 10, α0j = 0.7, or when the censoring
times were uniformly distributed are similar and are omitted for the sake of space. We
considered qn = 10r for r = −6,...,−2, and also ranging from 0.1 to 1 (corresponding to
no screening) in increments of 0.1. The results support our principled cutoﬀ procedure: the
observed false positive rates closely match the nominal qn when ρ = 0.5 for all censoring
rates. When ρ = 0.9, the observed false positive rates can be higher than the nominal qn
for qn ≤ 10−4, but since pn = 20000 here, qn = 10−4 corresponds to only 2 false positives.
In other words, even when the nominal qn underestimates the true false positive rate, the
absolute number of false positives selected by PSIS is still fairly small.
Figure 2.1 plots the average false negative rates for PSIS against qn, which increase
as qn decreases but generally don’t rise dramatically until qn ≈ 0.1. For a given qn the
false negative rates decrease with larger α0j. The performance of PSIS actually improves
when ρ = 0.9, perhaps because in our simulated data the correlation between the important
covariates increases with ρ, making the marginal ˆ βj estimates for those covariates more likely
to be similar in magnitude. Higher censoring rates exhibit worse performance, as expected.
These results suggest that qn can be set fairly low and the false negative rate will not suﬀer
38Table 2.1: Simulation results for Cox models with sn = 20, α0j = 0.35, and ρ = 0.5 under
exponential censoring
PSIS PSIS-L PSIS-A PSIS-S
% censoring qn | ˆ M| FN FP FN FP FN FP FN FP
20 1e-6 0.86 0.96 3e-7 0.96 0.00 0.96 0.00 0.96 0.00
20 1e-5 2.45 0.89 1e-5 0.89 0.00 0.89 0.00 0.90 0.00
20 1e-4 7.29 0.74 1e-4 0.75 0.00 0.75 0.00 0.78 0.00
20 1e-3 30.74 0.52 1e-3 0.56 0.00 0.57 0.00 0.80 0.00
20 0.01 223.46 0.27 0.01 0.50 0.00 0.51 0.00 0.60 0.00
20 0.10 2066.62 0.07 0.10 0.45 0.00 0.46 0.00 0.64 0.00
20 0.20 4084.34 0.04 0.20 0.45 0.00 0.46 0.00 1.00 0.00
20 0.30 6085.28 0.03 0.30 0.45 0.00 0.46 0.00 1.00 0.00
20 0.40 8087.81 0.02 0.40 0.45 0.00 0.46 0.00 1.00 0.00
20 0.50 10076.05 0.01 0.50 0.45 0.00 0.46 0.00 1.00 0.00
20 0.60 12063.53 0.01 0.60 0.45 0.00 0.46 0.00 1.00 0.00
20 0.70 14049.73 0.01 0.70 0.45 0.00 0.46 0.00 1.00 0.00
20 0.80 16035.60 0.00 0.80 0.45 0.00 0.46 0.00 1.00 0.00
20 0.90 18018.92 0.00 0.90 0.45 0.00 0.46 0.00 1.00 0.00
20 1.00 19999.97 0.00 1.00 0.45 0.00 0.46 0.00 1.00 0.00
50 1e-6 0.46 0.98 8e-7 0.98 0.00 0.98 0.00 0.98 0.00
50 1e-5 1.48 0.93 9e-6 0.93 0.00 0.93 0.00 0.94 0.00
50 1e-4 5.53 0.82 1e-4 0.83 0.00 0.83 0.00 0.87 0.00
50 1e-3 27.48 0.64 1e-3 0.69 0.00 0.70 0.00 0.84 0.00
50 0.01 218.90 0.37 0.01 0.70 0.00 0.71 0.00 0.80 0.00
50 0.10 2055.34 0.11 0.10 0.84 0.00 0.84 0.00 0.82 0.00
50 0.20 4066.57 0.06 0.20 0.85 0.00 0.86 0.00 1.00 0.00
50 0.30 6072.90 0.04 0.30 0.86 0.00 0.87 0.00 1.00 0.00
50 0.40 8071.28 0.03 0.40 0.86 0.00 0.87 0.00 1.00 0.00
50 0.50 10061.46 0.02 0.50 0.87 0.00 0.87 0.00 1.00 0.00
50 0.60 12055.20 0.02 0.60 0.87 0.00 0.87 0.00 1.00 0.00
50 0.70 14048.17 0.01 0.70 0.87 0.00 0.87 0.00 1.00 0.00
50 0.80 16034.58 0.00 0.80 0.87 0.00 0.87 0.00 1.00 0.00
50 0.90 18018.47 0.00 0.90 0.87 0.00 0.87 0.00 1.00 0.00
50 1.00 19999.97 0.00 1.00 0.87 0.00 0.87 0.00 1.00 0.00
70 1e-6 0.04 1.00 1e-6 1.00 0.00 1.00 0.00 1.00 0.00
70 1e-5 0.33 0.99 7e-6 0.99 0.00 0.99 0.00 0.99 0.00
70 1e-4 2.33 0.96 8e-5 0.96 0.00 0.96 0.00 0.97 0.00
70 1e-3 20.34 0.86 9e-4 0.89 0.00 0.89 0.00 0.95 0.00
70 0.01 200.62 0.63 0.01 0.98 0.00 0.98 0.00 0.97 0.00
70 0.10 2036.15 0.28 0.10 0.99 0.00 0.99 0.00 1.00 0.00
70 0.20 4056.93 0.17 0.20 0.99 0.00 0.99 0.00 1.00 0.00
70 0.30 6073.71 0.11 0.30 0.99 0.00 0.99 0.00 1.00 0.00
70 0.40 8074.10 0.08 0.40 0.99 0.00 0.99 0.00 1.00 0.00
70 0.50 10069.87 0.06 0.50 0.99 0.00 0.99 0.00 1.00 0.00
70 0.60 12061.20 0.04 0.60 0.99 0.00 0.99 0.00 1.00 0.00
70 0.70 14053.00 0.03 0.70 0.99 0.00 0.99 0.00 1.00 0.00
70 0.80 16036.78 0.02 0.80 0.99 0.00 0.99 0.00 1.00 0.00
70 0.90 18018.22 0.01 0.90 0.99 0.00 0.99 0.00 1.00 0.00
70 1.00 19999.98 0.00 1.00 0.99 0.00 0.99 0.00 1.00 0.00
39Table 2.2: Simulation results for Cox models with sn = 20, α0j = 0.35, and ρ = 0.9 under
exponential censoring
PSIS PSIS-L PSIS-A PSIS-S
% censoring qn | ˆ M| FN FP FN FP FN FP FN FP
20 1e-6 20.57 0.03 6e-5 0.26 0.00 0.27 0.00 0.65 0.00
20 1e-5 22.00 0.01 1e-4 0.25 0.00 0.26 0.00 0.64 0.00
20 1e-4 25.39 0.00 3e-4 0.26 0.00 0.27 0.00 0.65 0.00
20 1e-3 46.84 0.00 1e-3 0.29 0.00 0.32 0.00 0.68 0.00
20 0.01 237.31 0.00 0.01 0.43 0.00 0.45 0.00 0.65 0.00
20 0.10 2069.38 0.00 0.10 0.39 0.00 0.41 0.00 0.69 0.00
20 0.20 4082.82 0.00 0.20 0.37 0.00 0.40 0.00 1.00 0.00
20 0.30 6085.60 0.00 0.30 0.38 0.00 0.40 0.00 1.00 0.00
20 0.40 8080.28 0.00 0.40 0.38 0.00 0.40 0.00 1.00 0.00
20 0.50 10072.06 0.00 0.50 0.38 0.00 0.40 0.00 1.00 0.00
20 0.60 12063.09 0.00 0.60 0.38 0.00 0.39 0.00 1.00 0.00
20 0.70 14052.35 0.00 0.70 0.38 0.00 0.40 0.00 1.00 0.00
20 0.80 16041.30 0.00 0.80 0.38 0.00 0.39 0.00 1.00 0.00
20 0.90 18017.65 0.00 0.90 0.38 0.00 0.39 0.00 1.00 0.00
20 1.00 19999.98 0.00 1.00 0.38 0.00 0.40 0.00 1.00 0.00
50 1e-6 19.38 0.07 4e-5 0.35 0.00 0.37 0.00 0.72 0.00
50 1e-5 21.08 0.03 8e-5 0.34 0.00 0.36 0.00 0.71 0.00
50 1e-4 24.35 0.01 2e-4 0.34 0.00 0.36 0.00 0.72 0.00
50 1e-3 44.27 0.00 1e-3 0.30 0.00 0.32 0.00 0.74 0.00
50 0.01 229.40 0.00 0.01 0.50 0.00 0.53 0.00 0.69 0.00
50 0.10 2059.74 0.00 0.10 0.51 0.00 0.54 0.00 0.78 0.00
50 0.20 4075.78 0.00 0.20 0.51 0.00 0.55 0.00 1.00 0.00
50 0.30 6082.62 0.00 0.30 0.51 0.00 0.55 0.00 1.00 0.00
50 0.40 8076.19 0.00 0.40 0.51 0.00 0.54 0.00 1.00 0.00
50 0.50 10069.25 0.00 0.50 0.51 0.00 0.54 0.00 1.00 0.00
50 0.60 12056.07 0.00 0.60 0.51 0.00 0.54 0.00 1.00 0.00
50 0.70 14049.39 0.00 0.70 0.51 0.00 0.55 0.00 1.00 0.00
50 0.80 16035.47 0.00 0.80 0.52 0.00 0.55 0.00 1.00 0.00
50 0.90 18016.56 0.00 0.90 0.52 0.00 0.55 0.00 1.00 0.00
50 1.00 19999.99 0.00 1.00 0.52 0.00 0.55 0.00 1.00 0.00
70 1e-6 17.07 0.17 2e-5 0.49 0.00 0.51 0.00 0.78 0.00
70 1e-5 19.29 0.09 6e-5 0.45 0.00 0.47 0.00 0.77 0.00
70 1e-4 22.88 0.04 2e-4 0.40 0.00 0.43 0.00 0.76 0.00
70 1e-3 42.52 0.01 1e-3 0.35 0.00 0.39 0.00 0.74 0.00
70 1e-2 225.35 0.00 0.01 0.63 0.00 0.66 0.00 0.78 0.00
70 0.10 2047.36 0.00 0.10 0.65 0.00 0.68 0.00 0.86 0.00
70 0.20 4061.41 0.00 0.20 0.65 0.00 0.68 0.00 1.00 0.00
70 0.30 6066.76 0.00 0.30 0.65 0.00 0.68 0.00 1.00 0.00
70 0.40 8069.35 0.00 0.40 0.65 0.00 0.68 0.00 1.00 0.00
70 0.50 10063.83 0.00 0.50 0.65 0.00 0.68 0.00 1.00 0.00
70 0.60 12052.45 0.00 0.60 0.65 0.00 0.68 0.00 1.00 0.00
70 0.70 14041.27 0.00 0.70 0.65 0.00 0.68 0.00 1.00 0.00
70 0.80 16029.24 0.00 0.80 0.65 0.00 0.68 0.00 1.00 0.00
70 0.90 18015.47 0.00 0.90 0.65 0.00 0.68 0.00 1.00 0.00
70 1.00 19999.99 0.00 1.00 0.65 0.00 0.68 0.00 1.00 0.00
40Figure 2.1: False negative rates for Cox models with α0j = 0.35 (dashes) and α0j = 0.7
(solid) under exponential censoring.
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Figure 2.1 (Continued).
42much, as long as the amount of censoring is not too high.
The average false negative rates for PSIS-L, PSIS-L-A, and PSIS-S are also plotted in
Figure 2.1. The corresponding false positive rates are all very low and so are not plotted (see
Tables 2.1 and 2.2). The PSIS-S results give false negative rates of 1 for large qn because
the SCAD algorithm fails when the number of covariates is too large, so we already see the
usefulness of PSIS in facilitating computations. For all methods, higher values of α0j exhibit
lower false negative rates, and as before we see better performance when the covariates are
more correlated.
Interestingly, with 50% censoring, when qn is small the PSIS-L, PSIS-L-A, and PSIS-S
false negative rates are noticeably lower than those after running lasso, lasso-adaptive lasso,
or SCAD alone (i.e. qn = 1). This supports the use of PSIS prior to running regularized
regression. However, when the censoring rate is fairly low (20%) or fairly high (70%), this ef-
fect diminishes, to the point where PSIS actually degrades the performance of the regularized
regressions when ρ = 0.5 at 20% censoring. This could be because with low censoring, there
might already be suﬃcient data for the regularized regressions to select from the pn = 20000
covariates, even in the absence of PSIS. At the other extreme, when there is 70% censoring,
there might be so little data (with n = 100) that no regularized method, with or without
PSIS, would perform well.
To assess the robustness of our procedure, we also generated 200 datasets from log-normal
models. Each dataset had n = 100 and pn = 20000, and covariates Zi were generated using
the same procedure as above, for ρ = 0.5 or 0.9. Survival times Ti were generated according
to log(Ti) = αT
0Zi+ǫi, where ǫi followed a standard normal distribution and α0 had sn = 10
or 20 nonzero elements all equal to either 0.35 or 0.7. Censoring times were generated using
the same schemes and rates as before.
Tables 2.3 and 2.4 and Figure 2.2 show that PSIS can still perform very well when the
Cox model is misspeciﬁed. Again, the numerical results when sn = 10, α0j = 0.7, or the
43Table 2.3: Simulation results for log-normal models with sn = 20, α0j = 0.35, and ρ = 0.5
under exponential censoring
PSIS PSIS-L PSIS-A PSIS-S
% censoring qn | ˆ M| FN FP FN FP FN FP FN FP
20 1e-6 1.07 0.95 5e-7 0.95 0.00 0.95 0.00 0.95 0.00
20 1e-5 2.92 0.86 1e-5 0.87 0.00 0.87 0.00 0.88 0.00
20 1e-4 7.83 0.71 1e-4 0.72 0.00 0.72 0.00 0.76 0.00
20 1e-3 31.64 0.50 1e-3 0.54 0.00 0.54 0.00 0.74 0.00
20 0.01 225.09 0.25 0.01 0.45 0.00 0.46 0.00 0.54 0.00
20 0.10 2072.03 0.07 0.10 0.38 0.00 0.39 0.00 0.58 0.00
20 0.20 4086.02 0.04 0.20 0.38 0.00 0.39 0.00 1.00 0.00
20 0.30 6091.88 0.02 0.30 0.38 0.00 0.39 0.00 1.00 0.00
20 0.40 8096.85 0.01 0.40 0.38 0.00 0.39 0.00 1.00 0.00
20 0.50 10084.36 0.01 0.50 0.38 0.00 0.39 0.00 1.00 0.00
20 0.60 12071.20 0.01 0.60 0.38 0.00 0.39 0.00 1.00 0.00
20 0.70 14053.60 0.00 0.70 0.38 0.00 0.39 0.00 1.00 0.00
20 0.80 16035.81 0.00 0.80 0.38 0.00 0.39 0.00 1.00 0.00
20 0.90 18014.10 0.00 0.90 0.38 0.00 0.39 0.00 1.00 0.00
20 1.00 19999.96 0.00 1.00 0.38 0.00 0.39 0.00 1.00 0.00
50 1e-6 0.58 0.97 2e-6 0.97 0.00 0.97 0.00 0.97 0.00
50 1e-5 1.68 0.92 8e-6 0.92 0.00 0.92 0.00 0.93 0.00
50 1e-4 5.74 0.80 9e-5 0.81 0.00 0.81 0.00 0.85 0.00
50 1e-3 28.12 0.61 1e-3 0.66 0.00 0.66 0.00 0.82 0.00
50 0.01 217.45 0.35 0.01 0.63 0.00 0.65 0.00 0.74 0.00
50 0.10 2053.91 0.10 0.10 0.79 0.00 0.80 0.00 0.79 0.00
50 0.20 4066.55 0.05 0.20 0.81 0.00 0.82 0.00 1.00 0.00
50 0.30 6071.31 0.03 0.30 0.81 0.00 0.82 0.00 1.00 0.00
50 0.40 8071.39 0.02 0.40 0.82 0.00 0.82 0.00 1.00 0.00
50 0.50 10067.45 0.01 0.50 0.82 0.00 0.83 0.00 1.00 0.00
50 0.60 12061.88 0.01 0.60 0.82 0.00 0.83 0.00 1.00 0.00
50 0.70 14045.89 0.00 0.70 0.82 0.00 0.83 0.00 1.00 0.00
50 0.80 16030.90 0.00 0.80 0.82 0.00 0.83 0.00 1.00 0.00
50 0.90 18017.08 0.00 0.90 0.82 0.00 0.83 0.00 1.00 0.00
50 1.00 19999.99 0.00 1.00 0.82 0.00 0.83 0.00 1.00 0.00
70 1e-6 0.07 1.00 8e-7 1.00 0.00 1.00 0.00 1.00 0.00
70 1e-5 0.45 0.98 7e-6 0.98 0.00 0.98 0.00 0.99 0.00
70 1e-4 2.62 0.95 8e-5 0.95 0.00 0.95 0.00 0.96 0.00
70 1e-3 20.59 0.83 9e-4 0.86 0.00 0.87 0.00 0.93 0.00
70 0.01 201.80 0.59 0.01 0.98 0.00 0.98 0.00 0.96 0.00
70 0.10 2032.38 0.24 0.10 0.99 0.00 0.99 0.00 1.00 0.00
70 0.20 4057.72 0.15 0.20 0.99 0.00 0.99 0.00 1.00 0.00
70 0.30 6071.12 0.10 0.30 0.99 0.00 0.99 0.00 1.00 0.00
70 0.40 8075.48 0.07 0.40 0.99 0.00 0.99 0.00 1.00 0.00
70 0.50 10069.12 0.05 0.50 0.99 0.00 0.99 0.00 1.00 0.00
70 0.60 12056.30 0.04 0.60 0.99 0.00 0.99 0.00 1.00 0.00
70 0.70 14044.67 0.03 0.70 0.99 0.00 0.99 0.00 1.00 0.00
70 0.80 16029.99 0.02 0.80 0.99 0.00 0.99 0.00 1.00 0.00
70 0.90 18015.69 0.01 0.90 0.99 0.00 0.99 0.00 1.00 0.00
70 1.00 19999.99 0.00 1.00 0.99 0.00 0.99 0.00 1.00 0.00
44Table 2.4: Simulation results for log-normal models with sn = 20, α0j = 0.35, and ρ = 0.9
under exponential censoring
PSIS PSIS-L PSIS-A PSIS-S
% censoring qn | ˆ M| FN FP FN FP FN FP FN FP
20 1e-6 20.63 0.03 6e-5 0.25 0.00 0.25 0.00 0.63 0.00
20 1e-5 21.98 0.01 1e-4 0.23 0.00 0.24 0.00 0.62 0.00
20 1e-4 24.94 0.00 2e-4 0.23 0.00 0.25 0.00 0.63 0.00
20 1e-3 45.60 0.00 1e-3 0.26 0.00 0.29 0.00 0.65 0.00
20 0.01 232.98 0.00 0.01 0.35 0.00 0.37 0.00 0.54 0.00
20 0.10 2064.58 0.00 0.10 0.31 0.00 0.33 0.00 0.64 0.00
20 0.20 4079.41 0.00 0.20 0.30 0.00 0.33 0.00 1.00 0.00
20 0.30 6089.45 0.00 0.30 0.30 0.00 0.32 0.00 1.00 0.00
20 0.40 8089.52 0.00 0.40 0.30 0.00 0.32 0.00 1.00 0.00
20 0.50 10075.52 0.00 0.50 0.30 0.00 0.33 0.00 1.00 0.00
20 0.60 12064.03 0.00 0.60 0.30 0.00 0.32 0.00 1.00 0.00
20 0.70 14048.61 0.00 0.70 0.30 0.00 0.32 0.00 1.00 0.00
20 0.80 16031.75 0.00 0.80 0.30 0.00 0.33 0.00 1.00 0.00
20 0.90 18014.60 0.00 0.90 0.31 0.00 0.33 0.00 1.00 0.00
20 1.00 19999.98 0.00 1.00 0.31 0.00 0.33 0.00 1.00 0.00
50 1e-6 19.65 0.06 4e-5 0.32 0.00 0.34 0.00 0.68 0.00
50 1e-5 21.14 0.02 8e-5 0.30 0.00 0.32 0.00 0.68 0.00
50 1e-4 24.32 0.01 2e-4 0.30 0.00 0.32 0.00 0.68 0.00
50 1e-3 44.18 0.00 1e-3 0.24 0.00 0.25 0.00 0.69 0.00
50 0.01 229.64 0.00 0.01 0.43 0.00 0.46 0.00 0.63 0.00
50 0.10 2056.83 0.00 0.10 0.46 0.00 0.50 0.00 0.72 0.00
50 0.20 4067.93 0.00 0.20 0.47 0.00 0.50 0.00 1.00 0.00
50 0.30 6075.55 0.00 0.30 0.47 0.00 0.50 0.00 1.00 0.00
50 0.40 8067.98 0.00 0.40 0.47 0.00 0.50 0.00 1.00 0.00
50 0.50 10065.84 0.00 0.50 0.47 0.00 0.51 0.00 1.00 0.00
50 0.60 12059.20 0.00 0.60 0.46 0.00 0.50 0.00 1.00 0.00
50 0.70 14048.42 0.00 0.70 0.46 0.00 0.50 0.00 1.00 0.00
50 0.80 16028.41 0.00 0.80 0.47 0.00 0.50 0.00 1.00 0.00
50 0.90 18014.56 0.00 0.90 0.47 0.00 0.50 0.00 1.00 0.00
50 1.00 19999.97 0.00 1.00 0.47 0.00 0.50 0.00 1.00 0.00
70 1e-6 17.46 0.14 2e-5 0.41 0.00 0.44 0.00 0.75 0.00
70 1e-5 19.54 0.07 5e-5 0.37 0.00 0.39 0.00 0.73 0.00
70 1e-4 22.92 0.03 2e-4 0.32 0.00 0.35 0.00 0.72 0.00
70 1e-3 43.28 0.01 1e-3 0.35 0.00 0.38 0.00 0.69 0.00
70 0.01 229.22 0.00 0.01 0.57 0.00 0.60 0.00 0.75 0.00
70 0.10 2062.75 0.00 0.10 0.63 0.00 0.65 0.00 0.86 0.00
70 0.20 4080.23 0.00 0.20 0.63 0.00 0.65 0.00 1.00 0.00
70 0.30 6083.23 0.00 0.30 0.62 0.00 0.65 0.00 1.00 0.00
70 0.40 8080.86 0.00 0.40 0.62 0.00 0.65 0.00 1.00 0.00
70 0.50 10073.59 0.00 0.50 0.62 0.00 0.65 0.00 1.00 0.00
70 0.60 12067.05 0.00 0.60 0.62 0.00 0.65 0.00 1.00 0.00
70 0.70 14053.72 0.00 0.70 0.62 0.00 0.65 0.00 1.00 0.00
70 0.80 16038.41 0.00 0.80 0.62 0.00 0.65 0.00 1.00 0.00
70 0.90 18019.44 0.00 0.90 0.62 0.00 0.65 0.00 1.00 0.00
70 1.00 19999.99 0.00 1.00 0.62 0.00 0.65 0.00 1.00 0.00
45Figure 2.2: False negative rates for log-normal models with sn = 20, α0j = 0.35 (dashes),
and α0j = 0.7 (solid) under exponential censoring.
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Figure 2.2 (Continued).
47censoring times were uniformly distributed are omitted from the tables to save space. These
results follow the same trends as those of the correctly speciﬁed simulations discussed above.
In particular, the principled cutoﬀ procedure still shows good performance, and using PSIS
when qn is small can still lead to lower false negative rates than when qn = 1.
2.5 Analysis of the myeloma study
Recent advances in understanding the biological mechanisms underlying multiple myeloma
have oﬀered new possibilities for therapy (Hideshima et al., 2007). Time-to-event outcomes
oﬀer information about the progression of the disease, and in this vein several studies have
examined the relationship between gene expression levels and survival (Decaux et al., 2008).
In one such study conducted by Millennium Pharmaceuticals (Mulligan et al., 2007), mRNA
expression levels were collected using Aﬀymetrix U133A/B arrays from myeloma cells of
80 patients enrolled in a clinical trial of bortezomib (accession number GSE9782, trial 39).
Median survival time was 684 days after randomization, and 50% of the observations were
censored. We applied our methods to this data.
Expression values were measured for 44760 probesets, encompassing more than 22000
genes, and were log2-transformed. We performed PSIS and chose qn = 1/44760, for two
reasons. First, our simulation results suggest that for large ρ, the true false positive rate can
be larger than our nominal level, and genetic datasets are probably highly correlated. Second,
gene expression levels are very likely related to the survival outcomes, but only weakly so.
Many of our genes are probably not suﬃciently important, in the sense of Assumption 11,
so allowing even a small false positive rate would result in including a huge number of genes.
For these reasons, we want to control the false positive rate to the extent possible, but on
the other hand we cannot allow f = 0 or else γn = ∞. Thus we considered f = 1, which
leads to our choice of qn.
48Table 2.5: Predictive accuracies using myeloma data
PSIS, qn = 0.0001 Random probesets All probesets
Method C-stat (SD) Size (SD) C-stat (SD) Size (SD) C-stat (SD) Size (SD)
Lasso 0.60 (0.09) 11.43 (9.18) 0.15 (0.25) 3.33 (10.74) 0.33 (0.33) 20.91 (24.07)
Lasso-alasso 0.60 (0.09) 11.13 (8.97) 0.15 (0.25) 3.29 (10.60) 0.33 (0.33) 18.86 (21.74)
SCAD 0.60 (0.09) 7.13 (6.67) 0.33 (0.28) 2.48 (7.43) — —
We could not directly evaluate the performance of PSIS without knowing which genes
are “truly” important. Instead, we ran PSIS to get a screened model ˆ M and also randomly
selected | ˆ M| probesets. We then compared the prediction accuracies of PSIS-L, PSIS-L-
A, and PSIS-S to those obtained by ﬁtting lasso, lasso-adaptive lasso, and SCAD on the
randomly selected probesets. Using random genes as negative controls is common in these
type of experiments (Hofmann et al., 2002; Aerts et al., 2006; Fan et al., 2010). We also ﬁt
the regularized regression procedures on the full dataset, without any screening (i.e. qn = 1).
For each of these methods, we randomly partitioned the data into a 60-patient training
set and a 20-patient testing set. We then used the models ﬁt in the training set to calculate
scores for each subject in the testing set, and evaluated the predictive performance using
the C-statistic (Uno et al., 2011b). We repeated this entire process 200 times. Better
performances from the screened methods would provide evidence that PSIS is indeed ﬁnding
predictively important genes.
Table 2.5 reports the average C-statistics and model sizes obtained by our diﬀerent meth-
ods. We see that PSIS-L, PSIS-L-A, and PSIS-S perform much better than the corresponding
regressions ﬁt using randomly selected probesets. When we do not screen the data, SCAD
fails, and lasso and lasso-adaptive lasso do not perform as well as the screened versions.
Because of the selection consistency of the adaptive lasso (Zou, 2006; Zhang and Lu,
2007), we next applied PSIS-L-A with qn = 1/44760 to all 80 patients. Table 2.6 gives the
probesets we found to have nonzero parameter estimates, as well as their estimated coeﬃ-
cients. Indeed, our results include some genes previously found to be related to myeloma, e.g.
IGHV3-23 (Hadzidimitriou et al., 2006) and PRKDC (Shaughnessy and Barlogie, 2003). Fi-
49Table 2.6: Genes found using PSIS-L-A, qn = 0.0001
Probeset Gene Description Coeﬃcient
219999 at MAN2A2 mannosidase, alpha, class 2A, member 2 -0.27
207677 s at NCF4 neutrophil cytosolic factor 4, 40kDa -0.14
216510 x at IGHV3-23 immunoglobulin heavy variable 3-23 -0.35
222610 s at S100PBP S100P binding protein 0.15
203550 s at FAM189B family with sequence similarity 189, member B 0.06
208694 at PRKDC protein kinase, DNA-activated, catalytic polypeptide 0.12
223277 at C3orf75 chromosome 3 open reading frame 75 0.18
234980 at TMEM56 transmembrane protein 56 -0.37
213893 x at PMS2L5 postmeiotic segregation increased 2-like 5 0.26
217518 at MYOF myoferlin -0.13
202587 s at AK1 adenylate kinase 1 -0.11
232452 at LOC148824 hypothetical LOC148824 0.42
209217 s at WDR45 WD repeat domain 45 -1.29
226692 at SERF2 small EDRK-rich factor 2 -1.15
223114 at COQ5 coenzyme Q5 homolog, methyltransferase 0.29
nally, we evaluated the predictive performance of this model using an independent validation
dataset (accession number GSE9782, trials 24, 25, and 40). The model in Table 2.6 achieved
a C-statistic of 0.59, which matches the cross-validation estimate of Table 2.5. These results
indicate that PSIS is an eﬀective way to identify predictively important genes while control-
ling the false positive rate, and that implementing PSIS before regularized regression can
lead to more computationally amenable, interpretable models with high predictive power.
2.6 Discussion
This paper advances the ﬁeld in three distinct ways. First, we have demonstrated that
with censored outcomes, sure independence screening using marginal Cox regressions is a
theoretically justiﬁed, eﬀective way to reduce ultra-high-dimensional data to moderate sizes
before applying more sophisticated variable selection procedures. In particular, we have
described new, necessary condition on the dependence between the covariates and the cen-
soring distribution. Second, we have provided a simple, principled method to select the
number of variables to retain after screening and illustrated its eﬀectiveness with simulated
data. Our procedure could be easily extended to other screening methods. Finally, we have
demonstrated through the motivating myeloma example that pre-screening may improve risk
classiﬁcation and identify predictive genes. There are a number of ways to broaden the scope
50of our method. So far we have dealt only with covariates that are constant in time, and we
have not considered tied observations. Our method could also be extended to multivariate
survival, competing risks, and other extensions of the Cox model.
While our simulations suggest that PSIS performs well even with correlated covariates, it
would be interesting to explore other screening methods proposed speciﬁcally to deal with this
situation. One approach is the ISIS method of Fan and Lv (2008), which starts with an initial
model of potentially important covariates, regresses the residuals from the working model
on each of the remaining covariates to expand the working model, and iterates this process
in order to capture any important covariates that would be missed in univariate screening.
Residuals are unavailable with censored observations, but Fan et al. (2010) generalized this
iterative idea by working instead with log-likelihood ratios. Their formulation is easily
applied to the log-partial likelihood of the Cox model, which they have implemented in
the R package SIS. However, the theoretical properties of this procedure have not been
investigated.
Finally, our theoretical analysis of sure independence screening touches on some philo-
sophical questions about notions of variable importance. Biological phenomena often arise
from the complex interactions of genes and other factors whose individual eﬀects can be
fairly weak but still non-zero. Thus merely having a non-zero contribution to the model is
not a useful notion of importance, because then nearly every variable would be important.
It may be more useful to conceive of importance as a ﬁnite sample property, in the sense
that covariates whose signals are higher than the noise level of the estimator being used are
to be considered important. In our method, for instance, the so-called important covariates
satisfy Theorem 4, or else they could not be detected by marginal Cox regressions. Perhaps
a good variable selection technique is one that, instead of selecting every variable with a non-
zero contribution to the outcome, retains only those variables that, for a given n, meet the
ﬁnite-sample deﬁnition of importance as deﬁned in Theorem 4. The sure screening property
of our method indicates that as n increases, we get closer to achieving this goal.
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2.7 Appendix A: Assumptions
Let the true hazard function λ(x;Zi) be given by (2.1), and denote the true survival functions
of Ti and Ci as ST(x;Zi) = exp{−exp(αT
0 Zi)Λ0(x)} and SC(x;Zi) = P(Ci > x|Zi), where
the cumulative baseline hazard function Λ0(x) =
  x
0 λ0(s)ds. To conserve space we will write
these as ST and SC. For simplicity we will drop the subject-speciﬁc subscripts i, except in
the proof of Theorem 3. We will also need the following assumptions. We use notation
introduced in Section 2.3.1.
Assumption 5 There exists a neighborhood B of β0j such that for each t < ∞,
sup
x∈[0,t],β∈B
|S
(0)
j (β,x) − s
(0)
j (β,x)| → 0 (2.10)
in probability as n → ∞, s
(0)
j (β,x) is bounded away from zero on B × [0,t], and s
(0)
j (β,x)
and s
(1)
j (β,x) are bounded on B × [0,t].
Assumption 6 For each t < ∞ and j = 1,...,pn,
  t
0 s
(2)
j (x)dx < ∞.
Assumption 7 The true parameter vector α0 belongs to a compact set such that each com-
ponent α0j is bounded by a constant A > 0. Furthermore,  α0 1 is bounded by a constant
L > 0.
52Assumption 8 With τ (the study duration) as deﬁned in Section 2.3.1, Λ0(τ) is bounded
by a positive constant.
Assumption 9 There is some constant H > 0 such that n−1|Uj(ˆ βj)−Uj(β0j)| ≥ H|ˆ βj−β0j|
for all j = 1,...,pn.
Assumptions 5 and 6 are standard in survival analysis. Assumption 7 controls the total
eﬀect size of the covariates, which intuitively should be bounded and independent of sample
size. The bounded cumulative baseline hazard function required by Assumption 8 usually
holds in practice. Finally, Assumption 9 is reasonable because by the mean value theorem,
we know that n−1|Uj(ˆ βj) − Uj(β0j)| = |n−1Ij(β∗)||ˆ βj − β0j| for some β∗ between ˆ βj and
β0j. It can be shown that Ij(β∗) converges to the absolute value of the limiting information
−∂uj(β)/∂β evaluated at the true β0j (Fleming and Harrington, 2005), and it is reasonable
to assume that this limiting information is bounded from below away from zero. Thus for n
suﬃciently large, we can take H = infβ,j |∂uj(β)/∂β| such that H  = 0.
Our PSIS method will have good theoretical properties if the covariates Zi also satistify
the following reasonable assumptions. Versions of these assumptions have been previously
proposed (Fan and Lv, 2008; Fan and Song, 2010), but modiﬁcations are required when
working with censored data.
Assumption 10 The Zij are independent of time and bounded by a constant K > 0, and
E(Zij) = 0 for all j.
Assumption 11 If FT(x;Zi) is the cumulative distribution function of Ti given Zi, then for
constants c1 > 0 and κ < 1/2, minj∈M |cov[Zij,E{FT(Ci;Zi) | Zi}]| ≥ c1n−κ.
Assumption 12 The Zij, j ∈ Mc are independent of the Zij, j ∈ M and of Ci.
53The validity of our proposed screening procedure hinges on whether the misspeciﬁed
marginal Cox regressions can reﬂect the importance of the corresponding covariates in the
joint model. In general it is diﬃcult to directly link the true α0j to the marginal β0j because
of the phenomenon of unfaithfulness (Wasserman and Roeder, 2009), where the marginal
correlation of Zij with the outcome can be zero even if α0j is large, due to correlated covari-
ates. Assumption 11 protects against unfaithfulness. Though the outcome is unobservable
under censoring, FT(Ci;Zi) is the probability of observing a failure given Zi and is a sensible
surrogate. Assumption 12 is similar to the partial orthogonality assumption introduced in
Fan and Song (2010).
2.8 Appendix B: Proofs
2.8.1 Proof of Theorem 2
We ﬁrst relate β0j to cov[Zj,E{FT(C;Z) | Z}]. Assumptions 11 and 12 will then relate the
covariance to α0j.
First, integration by parts gives that
  τ
0
E{Zjλ0(x)exp(α
T
0Z)STSC}dx = cov[Zj,E{FT(C;Z) | Z}]. (2.11)
Next, we deﬁne the function
f(β) =
  τ
0
E{Zj exp(βZj)STSC}
E{exp(βZj)STSC}
E{λ0(x)exp(α
T
0Z)STSC}dx. (2.12)
Then since β0j is the solution to the estimating equation uj(β) (2.5), we know that
cov[Zj,E{FT(C;Z) | Z}] = f(β0j). We can use the Cauchy-Schwarz inequality to
show that ∂f(β)/∂β ≥ 0, with equality if and only if P{Zj exp(βZj/2)(STSC)1/2 =
cexp(βZj/2)(STSC)1/2} = 1 for some constant c. Since this will not hold if Zj is not
constant, we see that f(β) is a monotone-increasing function in β.
54Now suppose α0j = 0 so that j ∈ Mc. By Assumption 12, Zj is independent of
E{FT(C;Z) | Z}, so that f(β0j) = cov[Zj,E{FT(C;Z) | Z}] = 0. However, we also have
that f(0) = 0, since E{ZjSTSC} = E(Zj)E(STSC) = 0 by Assumption 10 and because Zj
and C are independent for j ∈ Mc. Because f(β) is monotone we know that there is only
one value of β such that f(β) = 0, so that β0j = 0. Similarly, suppose that α0j  = 0 so that
j ∈ M. Then by Assumption 11, |f(β0j)| = |cov[Zj,E{FT(C;Z) | Z}]| > c1n−κ. Therefore
β0j  = 0 by monotonicity, and we can conclude that α0j = 0 if and only if β0j = 0.
2.8.2 Proof of Theorem 3
We ﬁrst bound |Uj(ˆ βj) − Uj(β0j)| by the supremum of an empirical process, where Uj(β)
was deﬁned in (2.4). We then use the concentration theorem of Massart (2000) to derive a
maximal inequality. We will conclude by using Assumption 9 to extend this inequality to
|ˆ βj − β0j|.
First, let ¯ Uj(β) = n−1Uj(β). Since we still have ¯ Uj(ˆ βj) = 0, we can write |¯ Uj(ˆ βj) −
¯ Uj(β0j)| = |¯ Uj(β0j)|. Because ¯ Uj(β0j) is not a sum of independent terms, we cannot di-
rectly apply empirical process techniques. However, we know from Lin and Wei (1989) that
¯ Uj(β0j) = n−1  n
i=1 w
(j)
i (β0j) + op(1), where
w
(j)
i (β0j) =
  τ
0
 
Zij −
E{Zij exp(β0jZij)STSC}
E{exp(β0jZij)STSC}
 
dNi(x)− (2.13)
  τ
0
Yi(x)exp(β0jZij)
E{exp(β0jZij)STSC}
 
Zij −
E{Zij exp(β0jZij)STSC}
E{exp(β0jZi)STSC}
 
E{dNi(x)}. (2.14)
and the w
(j)
i (β0j) are independent. Furthermore, it is easy to show that E{w
(j)
i (β0j)} = 0. If
we let En denote the empirical measure, then we can write |¯ Uj(ˆ βj) − ¯ Uj(β0j)| ≤ supβ |(En −
E)w
(j)
i (β)| + op(1). Thus |¯ Uj(ˆ βj) − ¯ Uj(β0j)| is bounded by the sum of the supremum of an
empirical process and a term that converges to zero in probability.
To derive a maximal inequality for this process, we ﬁrst ﬁnd a bound on w
(j)
i (β) uni-
form over β and j = 1,...,pn. Using Assumptions 7, 8, and 10, we can write that
55|w
(j)
i (β)| ≤ 2K[1+Λ0(τ)exp{2K(A+L)}] for j = 1,...,pn. Next, we must ﬁnd a bound on
the expected value of our supremum. Let εi, i = 1,...,n be an independent, identically dis-
tributed sequence of random variables taking values ±1 with probability 1/2. In particular,
they are independent of Z. Then E{supβ |(En − E)w
(j)
i (β)|} ≤ 2E[supβ |En{εiw
(j)
i (β)}|], by
Lemma 2.3.1 of van der Vaart and Wellner (1996). But by the Cauchy-Schwarz inequality,
independence of εi and Zi, and the bound on |w
(j)
i (β)| derived above, we can show that the
right side is bounded by 4K[1 + Λ0(τ)exp{2K(A + L)}]{var(n−1  n
i=1 εi)}1/2. Then from
the concentration theorem of Massart (2000), we know that
P
 
sup
β
|(En − E)w
(j)
i (β)| ≥ n
−1/24K[1 + Λ0(τ)exp{2K(A + L)}](1 + t)
 
≤ exp(−t
2/2). (2.15)
Finally, we can relate this inequality back to |ˆ βj − β0j| with Assumption 9, though we
must also deal with the op(1) term. Using a previously proven inequality, |ˆ βj − β0j| ≤
H−1 supβ |(En − E)w
(j)
i (β)| + op(1), so we can write
P
 √
n|ˆ βj − β0j| ≥ 4K[1 + Λ0(τ)exp{2K(A + L)}](1 + t)/H
 
≤
P
 
sup
β
|(En − E)w
(j)
i (β)| + op(1) ≥ n
−1/24K[1 + Λ0(τ)exp{2K(A + L)}](1 + t)
 
. (2.16)
But for any ǫ > 0, P(A + B ≥ c) ≤ P(A ≥ c − ǫ) + P(B ≥ ǫ), where A and B are random
variables and c is a constant. We conclude by combining this with (2.15) and (2.16) and
taking ǫ arbitrarily close to 0.
2.8.3 Proof of Theorem 4
From Theorem 2, we know that β0j  = 0 if j ∈ M. Then by Theorem 2.1 of Struthers and
Kalbﬂeisch (1986) and the mean value theorem, we know that |uj(0)| = |uj(β0j) − uj(0)| =
|u′
j(β∗)||β0j| for some β∗ between β0j and 0, where u′
j(β) = duj(β)/dβ. We will ﬁrst bound
u′
j(β) and then use Assumption 11 to conclude.
56Integrating by parts, we can show that |u′
j(β)| ≤ 2K2|E{ST(C;Z) | Z}|. But
E{ST(C;Z) | Z} is bounded by 1, so
|β0j| ≥ 0.5K
−2
       cov[Zj,E{FT(C;Z) | Z}] −
  τ
0
E(ZjSTSC)
E(STSC)
E{λ0(x)exp(α
T
0Z)STSC}dx
       .
(2.17)
Because STSC is the probability of being at risk at time x, we can intuitively see, and also
prove, that E(ZjSTSC) = cov(Zj,STSC) and cov[Zj,E{FT(C;Z) | Z}] have opposite signs.
This implied that j ∈ M, |β0j| ≥ 0.5K−2|cov[Zj,E{FT(C;Z) | Z}]|, and Assumption 11
gives minj∈M |β0j| ≥ c2n−κ for c2 = 0.5K−2c1.
2.8.4 Proof of Theorem 5
We ﬁrst derive a probability bound for the standardized marginal regression parameters. We
can then use this bound to ﬁnd P(M ⊆ ˆ M).
Let 1 + t = c2Hn1/2−κ/(8K[1 + Λ0(τ)exp{2K(A + L)}]), with c2 and κ as deﬁned in
Theorem 4 and K,Λ0(τ),A, and L as deﬁned in Theorem 3. Then by Theorem 3 there
exists a constant c3 such that P(|ˆ βj − β0j| ≥ c2n−κ/2) ≤ exp(−c3n1−2κ).
If we now set our cutoﬀ γn = Φ−1(1−qn/2), then we can write the probability of retain-
ing the important covariates as 1 − P{minj∈M Ij(ˆ βj)1/2|ˆ βj| < γn} ≥ 1 − P{minj∈M |ˆ βj| ≤
γn(Hn)−1/2}. Using Theorem 4 we can show that c2n−κ − |ˆ βj| ≤ |β0j − ˆ βj|, j ∈ M,
so P{minj∈M |ˆ βj| ≤ γn(Hn)−1/2} ≤ P{maxj∈M |ˆ βj − β0j| ≥ c2n−κ − γn(Hn)−1/2}. If
we have γn ≤ c2H1/2n1/2−κ/2, then the probability bound above gives P(M ⊆ ˆ M) ≥
1 − exp(−c3n1−2κ).
Finally, since qn = f/pn, the requirement on γn can be rewritten as pn ≤ (f/2){1 −
Φ(c2H1/2n1/2−κ/2)}−1. Using the fact that 1 − Φ(x) ≤ x−1 exp(−x2/2), this inequality can
be satisﬁed if pn ≤ f/2exp(c2
2Hn1−2κ/8). Thus the sure screening property holds as long as
57log(pn) = O(n1−2κ).
2.8.5 Proof of Theorem 6
We ﬁrst show that for j ∈ Mc, Uj(β) evaluated at the true β0j can be approximated by a
sum of continuous-time martingales, just as it can in a correctly speciﬁed Cox regression.
We can then appeal to an Edgeworth expansion by Gu (1992) to conclude.
By Theorem 2 we know that β0j = 0 for j ∈ Mc. Thus we can rewrite (2.4) as
Uj(β0j) =
n  
i=1
  τ
0
 
Zij −
n−1  
l ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl
 
dNi(x)+ (2.18)
n  
i=1
  τ
0
 
n−1  
l ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl −
n−1  
l ZljYl(x)
n−1  
l Yl(x)
 
dNi(x) (2.19)
=
n  
i=1
  τ
0
 
Zij −
n−1  
l ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl
 
dMi(x)+ (2.20)
n
−1
n  
l=1
  τ
0
 
ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl −
ZljYl(x)
n−1  
l Yl(x)
 
n  
i
dNi(x), (2.21)
where Mi(x) = Ni(x) −
  x Yi(t)λ0(t)eαT
0 Zidt is a continuous martingale in x.
Now let Sm =
 m
l=1 ξl, where
ξl =
 
ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl −
ZljYl(x)
n−1  
l Yl(x)
 
n  
i
dNi(x). (2.22)
Note that E(ξm | Sm−1) = E{E(ξm | Sm−1,Zm) | Sm−1}, and
E(ξm | Sm−1,Zm) = ZmjE
  
Ym(x)eαT
o Zm
n−1  
l Yl(x)eαT
o Zl −
Ym(x)
n−1  
l Yl(x)
 
n  
i
dNi(x)
         
Sm−1,Zm
 
.
(2.23)
Given Sm−1, the conditional expectation on the right-hand side above is a random variable
in Zmk,k ∈ M only, and by Assumption 12 is independent of Zmj,j ∈ Mc. Since E(Zmj |
Sm−1) = E(Zlj) = 0 by Assumption 10, we ﬁnd that E(ξm | Sm−1) = 0, implying that Sm is
58a discrete martingale in m. Then when m = n, by the inequality of Dharmadhikari et al.
(1968) we have that E(|n−1Sn|p) = Dn−p/2 for p ≥ 2, where we can show that D does not
depend on j.
We have shown that for j ∈ Mc,
Uj(β0j) =
n  
i=1
  τ
0
 
Zij −
n−1  
l ZljYl(x)eαT
o Zl
n−1  
l Yl(x)eαT
o Zl
 
dMi(x) + n
−1Sn, (2.24)
where n−1Sn satisﬁes the same conditions as R1,n in (4.3) of Gu (1992). We can therefore
extend the proof of Theorem 2.1 in Gu (1992) to show that
sup
x
     P{Ij(ˆ βj)
1/2|ˆ βj| ≥ x} − Φ(x)
      ≤ c4n
−1/2, (2.25)
where c4 does not depend on j. Then (2.6) implies
E


      ˆ M ∩ Mc
     
|Mc|

 ≤
1
pn − sn
 
j∈Mc
 
2{1 − Φ(γn)} + c4n
−1/2 
. (2.26)
The result follows if we choose γn = Φ−1(1 − qn/2).
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603.1 Introduction
Modern high-throughput experiments are producing high-dimensional datasets with ex-
tremely large numbers of covariates. Traditional regression modeling strategies work poorly
in such situations, leading to recent interest in regularized regression methods such as the
lasso (Tibshirani, 1996), the Dantzig selector (Cand` es and Tao, 2007), and SCAD (Fan and
Li, 2001). These procedures can perform well in estimation and prediction even when the
number of covariates pn is larger than the sample size n, where here we are allowing pn to
grow with n. However, when pn is extremely large compared to n, these methods can be-
come inaccurate and computationally infeasible (Fan and Lv, 2008). Thus there is a need for
methods to quickly screen out unimportant covariates before using regularization methods.
A number of screening strategies have so far been proposed, and choosing which one to
use depends on what model we believe is most suitable for the data. Under the ordinary
linear model, Fan and Lv (2008) proposed a procedure with the sure screening property,
where the covariates retained after screening will contain the truly important covariates
with probability approaching one, even in the ultra-high-dimensional realm where pn grows
exponentially with n. Fan and Song (2010) and Zhao and Li (2012) subsequently proposed
procedures that maintain this property for generalized linear models and the Cox model,
respectively. Screening methods have also been proposed for nonparametric additive models
(Fan et al., 2011), linear transformation models (Li et al., 2011), and single-index hazard
models (Gorst-Rasmussen and Scheike, 2011).
In a recent development, Zhu et al. (2011) proposed a screening method valid for any
single-index model, a class so large that their screening procedure is nearly model-free.
They used a new measure of dependence which can detect a wide variety of functional
relationships between the covariates and the outcome, and proved that their method has
the sure screening property for any single-index model. They also showed in simulations
that it could signiﬁcantly outperform model-based screening methods when the models were
61incorrectly speciﬁed.
On the other hand, model-based screening can have greater power to detect important
covariates, a consequence of the bias-variance tradeoﬀ. However, there are often situations
where we wish to use some model other than the ones mentioned above. For example,
studies involving clustered observations, missing data, or censored outcomes are frequently
encountered in genomic medicine, and are often analyzed with more complicated regression
models for which no screening methods have yet been developed. In theory it is not diﬃcult
to propose a screening procedure for any given model: ﬁt pn marginal regressions, one for
each covariate, and retain those covariates with the largest marginal estimates, in absolute
value. But ﬁtting pn marginal regressions can still be time-consuming, especially if pn is
very large and the ﬁtting procedure is slow, and theoretical properties such as sure screening
must still be studied on a case-by-case basis.
In this paper we propose EEScreen, a uniﬁed approach to screening which can be used
with any statistical model that can be ﬁt using estimating equations. This is convenient
because estimating equations are frequently used to analyze the previously mentioned cor-
related, missing, or censored data situations. EEScreen is also fundamentally diﬀerent from
most other screening procedures in that it only requires evaluating pn estimating equations
at a ﬁxed parameter value, rather than solving for pn marginal regressione estimates, making
it exceedingly computationally convenient. We prove theoretical results about the screen-
ing properties of EEScreen that hold for any model that can be ﬁt using U-statistic-based
estimating equations.
Furthermore, because we can design estimating equations to incorporate more or fewer
modeling assumptions, we can use our EEScreen framework to span the range between
model-based and model-free screening. In particular, we show that EEScreen can provide
a screening method very similar to that of Zhu et al. (2011) when used with a particular
estimating equation. This estimating equation actually cannot be used for estimation in
practice because it involves unknown parameters, but interestingly can still be used to derive
62a useful screening procedure.
Finally, when covariates are highly correlated, Fan and Lv (2008) suggested an iterative
version of their screening procedure, which they found to outperform marginal screening in
some cases. In this paper we provide an iterative version of EEScreen (iEEScreen), and we
also demonstrate a novel connection between iEEScreen and EEBoost, a recently proposed
boosting algorithm for estimation and variable selection in estimating equations (Wolfson,
2011). This connection may provide a means for a theoretical analysis of iterative screening
methods, something which so far has been diﬃcult to study.
We introduce EEScreen in Section 3.2, where we also give some examples, establish its
theoretical properties, and brieﬂy discuss how to choose the number of covariates to retain
after screening. We derive a new screening method similar to that of Zhu et al. (2011)
in Section 3.3, and discuss iEEScreen in Section 3.4. We conduct a thorough simulation
study in Section 3.5, using two diﬀerent estimating equations, before applying our methods
to analyze an issue in multiple myeloma in Section 3.6. We conclude with a discussion in
Section 3.7, and provide proofs in the Appendix.
3.2 EEScreen: sure screening for estimating equations
3.2.1 Method
Let Yi = (Yi1,...,YiKi)T be a Ki×1 outcome vector and Xi = (Xi1,...,XiKi)T be a Ki×pn
matrix of covariates for units i = 1,...,n. Then let Y = (Y1,...,Yn)T be a
 
i Ki × 1
vector and X = (XT
1,...,XT
n)T be a
 
i Ki × pn matrix. Assuming some regression model,
we can construct a pn × 1 estimating equation U(β) that depends on Yi and Xi such that
E{U(β0)} = 0, where β0 is the true pn × 1 parameter vector. Let the set of true regression
parameters M = {j : β0j  = 0} have size |M| = sn, where β0j is the jth component of β0.
63It is commonly assumed that sn is small and ﬁxed or growing slowly. When pn < n, β0
is estimated by ﬁnding the ˆ β such that U(ˆ β) = 0, but when pn > n there are an inﬁnite
number of solutions for ˆ β, in which case regularized regression is used (Fu, 2003; Johnson
et al., 2008; Wolfson, 2011). However, when pn is much greater than n, these methods can
lose accuracy and be too computationally demanding, hence the need for screening methods
to quickly reduce pn.
Most previously proposed screening methods proceed by ﬁtting pn regression models,
one covariate at a time, to get pn marginal estimates ˆ αj. They then retain the covariates
with |ˆ αj| above some threshold. This is akin to conducting pn Wald tests, though without
standardizing the ˆ αj by their variances. However, in the case of estimating equations, even
this procedure can be time-consuming if pn is large or U is cumbersome to ﬁt.
Here, instead of marginal Wald tests, we construct marginal score tests for the β0j using
U. To motivate our procedure, we ﬁrst consider the case where the marginal model is correct
for β01. In other words, β01  = 0 while β0j = 0 for all j  = 1. Then E[U{(β01,0,...,0)}] = 0,
so that each component of U is a valid estimating equation for β01. This implies that each
component of U(0) is the numerator of a score test for the null hypothesis β01 = 0. If the
marginal model is correct for β01, then to achieve sure screening we must reject the score
test. Therefore we use as our screening statistic the component of U(0) that gives the most
powerful test, which we denote U1(0). For each j, we can identify the component Uj(0) of
U(0) that is most powerful for testing β0j = 0 under the marginal model that β0j is the only
non-zero parameter. In many situations the ﬁrst component of U(0) will be associated with
β01, the second with β02, and so on. When this is not the case, we can follow the construction
above to relabel the components of U(0) appropriately.
We propose using the relabeled Uj(0) as surrogate measures of association between the
outcome and the jth covariate, after ﬁrst standardizing the covariates to have equal variances.
Instead of just taking the numerators of the score tests we could divide each Uj(0) by an
estimate of its standard deviation, but this would add computational complexity to our
64procedure, and even without doing so we will be able to achieve good results and prove
ﬁnite-sample performance guarantees. One advantage to using score tests is that they do not
require parameter estimation and so are more computationally convenient than performing
pn marginal regressions. Furthermore, this framework will also allow us to give a uniﬁed
treatment of the theoretical results for a large class of estimating equations.
Speciﬁcally, we propose the following screening procedure:
1. Standardize the pn covariates to have variance 1.
2. For the jth parameter identify the marginal estimating equations Uj as described above.
3. Set a threshold γn.
4. Retain the parameters {j : |Uj(0)| ≥ γn}.
We will denote the set of retained parameters by ˆ M. Note that this procedure only re-
quires evaluating pn estimating equations at 0, which can be computed very quickly. The
convenience of score tests, however, comes at the price of ambiguity in the proper treatment
of nuisance parameters, such as the intercept term in a regression model. Without loss of
generality, let β01 be the intercept term. We can ﬁrst ﬁt the intercept without any covariates
in the model to get an estimate ˆ β01. This only needs to be done once, since ˆ β01 will remain
the same for each Uj. We then screen by evaluating each Uj at η = (ˆ β01,0) instead of at 0.
Our score test idea was motivated by the EEBoost algorithm (Wolfson, 2011), a boosting
procedure for estimating equations which uses components of the estimating equation U as
a surrogate measure of association. We therefore refer to our method as EEScreen, and we
will draw more connections between EEScreen and EEBoost in Section 3.4.
653.2.2 Examples
Here we provide some examples of EEScreen for various estimating equations, assuming
throughout that E(Xi) = 0 and var(Xij) = 1. For the linear model with Ki = 1, the usual
linear regression score equation is U(β) = XT(Y − Xβ), so U(0) = XTY. Under the
marginal model that β0j′ is the only non-zero parameter, the jth component of E{U(0)}
equals cor(Xij,Xij′)β0j′, where Xij is the jth component of the ith covariate vector. Clearly
this is maximized when j = j′ for any value of β0j′, so the component of U(0) that gives the
most powerful test is Uj′(0). EEScreen then retains the parameters {j : |
 
i XijYi| ≥ γn}.
Note that this is equivalent to the original screening procedure proposed by Fan and Lv
(2008).
Under the Cox model, when Ki = 1 with survival outcomes, let Ti be the survival time,
Ci the censoring time, Yi = min(Ti,Ci), and δi = I(Ti ≤ Ci). The Cox model score equation
is
U(β) =
n  
i=1
   
Xi −
 n
i=1 Xi˜ Yi(x)exp(XT
i β)
 n
i=1 ˜ Yi(x)exp(XT
i β)
 
d ˜ Ni(x), (3.1)
where ˜ Ni(x) = I(Ti ≤ x,δi) is the observed failure process and ˜ Yi(x) = I(Yi ≥ x) is the
at-risk process. Under the marginal model that β0j′ is the only non-zero parameter, Gorst-
Rasmussen and Scheike (2011) show that the largest component of the limiting estimating
equation evaluated at 0 is found for the j that maximizes
 
cor{Xij,F(t | Xij′)}, where
F(t | Xij′) is the distribution function of Ti, conditional on Xij′. Thus the component of
U(0) that gives the most powerful test is again the j′th component. EEScreen then retains
the parameters  
j :
         
n  
i=1
   
Xij −
 n
i=1 Xij ˜ Yi(x)
 n
i=1 ˜ Yi(x)
 
d ˜ Ni(x)
         
≥ γn
 
. (3.2)
This is exactly the screening statistic of Gorst-Rasmussen and Scheike (2011). This example
illustrates the computational advantages that EEScreen can enjoy. Zhao and Li (2012)
proposed screening for the Cox model based on ﬁtting marginal Cox regressions, which
requires pn applications of the Newton-Raphson algorithm. In contrast, Gorst-Rasmussen
66and Scheike (2011) and EEScreen only require evaluating the Uj(0).
The ordinary linear model and the Cox model have already been studied in the screening
literature, but EEScreen is most useful for models for which no screening procedures exist
yet. In Sections 3.5 we study its performance on two such models: a t-year survival model
(Jung, 1996) and the accelerated failure time model (Tsiatis, 1996; Jin et al., 2003).
3.2.3 Theoretical properties
One advantage of our EEScreen framework is that we can provide very general theoretical
guarantees on its screening performance that hold for a large class of models, without needing
to study each model on a case-by-case basis. We require three assumptions on the marginal
estimating equations Uj to prove that EEScreen has the sure screening property, where the
probability that the retained parameters ˆ M contains the true parameters M approaches
1. Let the expected full estimating equations be denoted u(β) = E{U(β)}, so that the
expected marginal estimating equations are uj(β).
Assumption 13 Let Xij be the Ki × 1 vector of the jth covariate for the ith unit. Each
estimating equation Uj has the form
Uj(β) =
 
n
m
 −1  
1≤i1<...<im
hj{β;(Yi1,Xi1),...,(Yim,Xim)} (3.3)
for all j, where n ≥ m and hj is a real-valued kernel function that depends on β and is
symmetric in the (Yi1,Xi1),...,(Yim,Xim).
Assumption 14 There exist some constants b > 0 and Σ2 > 0 such that for all j, |Uj(0)−
uj(0)| ≤ b and var[hj{0;(Yi1,Xi1),...,(Yim,Xim)}] ≤ Σ2.
67Assumption 13 requires that each Uj be a U-statistic of order m, which encompasses a
large number of important estimating equations. Assumption 14 amounts to conditions on
the moments of the Uj, and they can often be satisﬁed by assuming bounded outcomes and
covariates. These conditions are necessary for stating a Bernstein-type inequality for the
Uj, which gives the probability bounds in Theorems 7 and 8. They can therefore be relaxed
as long as there exists a similar probability inequality for Uj. For example, Bernstein-type
inequalities exist for martingales (van de Geer, 1995), which would allow Uj to be the Cox
model score equations.
Assumption 15 There exists some constant c1 > 0 such that minj∈M |uj(0)| ≥ c1[n/m]−κ
with 0 < κ < 1/2, where m is deﬁned in Assumption 13 and [n/m] is the largest integer less
than n/m.
Assumption 15 is an assumption on the marginal signal strengths of the covariates in
M. In EEScreen these signals are quantiﬁed by the uj(0), and Assumption 15 requires
them to be of at least a certain order so that they are detectable given a sample size n. An
assumption of this type is always needed in a theoretical analysis of a screening procedure.
For example, in the generalized linear model setting, our Assumption 15 is exactly equivalent
to the assumption of Fan and Song (2010) that the magnitude of the covariance between
E(Yi | Xi) and the jth covariate be of order n−κ. Since EEScreen is similar to conducting
pn score tests, Assumption 15 is similar to requiring that the expected value of the marginal
score test statistic for j ∈ M be of a certain order. As previously mentioned, we could
standardize the screening statistic |uj(0)| by its variance, in which case the score test analogy
would be exact. It is very reasonable to use the marginal score test statistic as a proxy for
the marginal association of the covariates.
Under these assumptions, we can show that EEScreen possesses the sure screening prop-
erty.
68Theorem 7 Under Assumptions 13–15, if γn = c1[n/m]−κ/2 for 0 < κ < 1/2, with m
deﬁned in Assumption 13, then
P(M ⊆ ˆ M) ≥ 1 − 2sn exp
 
−
c2
1[n/m]1−2κ/4
2Σ2 + bc1[n/m]−κ/3
 
, (3.4)
with Σ2 and b deﬁned in Assumption 14.
Theorem 7 guarantees that all important covariates will be retained by EEScreen with
high probability. Similar to previous work, we ﬁnd that this probability bound depends
only on sn and not on pn. The bound also depends on m, the order of the U-statistic, so
that EEScreen may not perform as well for larger m. Theorem 7 is almost an immediate
consequence of properties of U-statistics, and the simplicity of the proof is due to the fact
that EEScreen uses score tests instead of Wald tests. We therefore do not need to estimate
any parameters, nor prove probability inequalities for those estimates, which is a major
source of technical diﬃculty in previous work on screening.
Theorem 7 is most useful if the size of the ˆ M produced by EEScreen is small. In
other words, we hope that ˆ M does not contain too many false positives. With two more
assumptions, we can provide a bound on | ˆ M| that holds with high probability.
Assumption 16 The expected full estimating equation u(β) is diﬀerentiable with respect to
β. Let the negative Jacobian −∂u/∂β be denoted i(β).
Assumption 17 There exists some constant c2 > 0 such that  β0 2 ≤ c2.
Assumption 16 can hold even if the sample estimating equation U is nondiﬀerentiable.
Assumption 17 merely requires that there exist an upper bound on the size of the true β0
that does not grow with n, which is a reasonable condition.
69Theorem 8 Under Assumptions 13–17, if γn = c1[n/m]−κ/2 as in Theorem 7, then
P
 
| ˆ M| ≤
16c2
2σ∗2
max
c2
1[n/m]−2κ
 
≥ 1 − 2pn exp
 
−
c2
1[n/m]1−2κ/16
2Σ2 + bc1[n/m]−κ/6
 
, (3.5)
where Σ2 and b are deﬁned in Assumption 14 and σ∗
max = sup0<t<1 σmax{i(tβ0)}, where
σmax(A) denotes the largest singular value of the matrix A.
Like Theorem 7, Theorem 8 is also almost a simple consequence of properties of U-
statistics. Theorem 8 provides a ﬁnite-sample probability bound on | ˆ M|, but asymptotically
we would need assumptions on i(β
∗) to guarantee that σ∗
max will not increase too quickly. In
particular, if σ∗
max increased only polynomially in n, | ˆ M| would increase polynomially. At the
same time, the probability that the bound holds tends to one even if logpn = o([n/m]1−2κ),
so the false positive rate would decrease quickly to zero with probability approaching one
even in ultra-high dimensions. A similar phenomenon was found by Fan et al. (2011).
The presence of σ∗
max in Theorem 8 reﬂects the dependence of | ˆ M| on the degree of
collinearity of our data. For general estimating equations, collinearity not only depends on
the design matrix, but also varies across the parameter space. For example, Mackinnon and
Puterman (1989) and Lesaﬀre and Marx (1993) showed that generalized linear models can
be collinear even if their design matrices are not, and vice versa. In our situation, we are
concerned with collinearity along the line segment between β0 and 0. Note that because
σ∗
max depends only on i, β0, and 0, which are all nonrandom quantities, σ∗
max is nonrandom
as well.
3.2.4 Choosing γn
Theorems 7 and 8 specify optimal rates for γn, and a number of methods have been proposed
for choosing γn in practice. Fan and Lv (2008) suggested choosing γn such that | ˆ M| = n−1
or n/logn. Because these values are hard to interpret, Zhao and Li (2012) showed that
70γn is related to the expected false positive rate of screening. Zhu et al. (2011) also recently
proposed a thresholding method based on adding artiﬁcial auxiliary variables, and provided a
bound relating the number of added variables to the probability of including an unimportant
covariate. These methods oﬀer more interpretable ways of choosing how many covariates to
retain with EEScreen. A related strategy is to set a desired false discovery rate. Bunea et al.
(2006) showed that FDR methods can achieve the sure screening property in the ordinary
linear model, and Sarkar (2004) proposed an FDR method than can also control the false
negative rate. It would be interesting to pursue this type of idea for EEScreen.
In practice, however, we are often concerned with the prediction error of the estimator
obtained by ﬁtting a regularized regression method after EEScreen. If we used the methods
above we would still need to choose a false positive rate or false discovery rate, but so far it is
not clear what choices would give optimal prediction. In this case another option is to retain
diﬀerent numbers of covariates, ﬁt the regularized regression for each screened model ˆ M,
and select the ˆ M that gives the lowest cross-validated estimate of prediction error. This is
the approach we take in Section 3.6, where we use EEScreen to analyze data from a multiple
myeloma clinical trail.
3.3 Model-free screening
Zhu et al. (2011) recently proposed a screening statistic that can achieve sure screening
for any single-index model. Speciﬁcally, for a completely observed response ˜ Yi and a p-
dimensional covariate vector Xi, they assumed that F(y | Xi) = F0(y | XT
i β0), where
F(y | Xi) = P(˜ Yi < y | Xi) and F0 is some distribution function that depends on Xi
only through the index XT
i β0, so that j ∈ M if and only if β0j  = 0. This is a very mild
assumption that holds for a large class of models, making the screening method of Zhu et al.
(2011) almost model-free.
71To simplify things, they assumed that E(Xi) = 0 and var(Xi) = Ipn, where Ipn is the
pn × pn identity matrix. They quantiﬁed the marginal relationship between the covariates
and an outcome y by using the novel statistic
Ω(y) = E{XiF(y | Xi)} = cov{Xi,F(y | Xi)} = cov{Xi,I(˜ Yi < y)}. (3.6)
Intuitively, the covariance between Xij and F(˜ Yi | Xi), where Xij is the jth component of Xi,
should be large in magnitude if j ∈ M. They therefore used ωj = E{Ωj(˜ Yi)2} as a measure
of marginal association, where Ωj(y) is the jth component of Ω(y), leading to the screening
statistic
˜ ωj = n
−1
n  
k=1
 
n
−1
n  
i=1
XijI(˜ Yi < ˜ Yk)
 2
. (3.7)
This derivation of the screening procedure of Zhu et al. (2011) makes no mention of
estimation of β0, making it seemingly irreconcilable with our EEScreen, which requires
an estimating equation. However, we can actually show that EEScreen, combined with a
particular estimating equation, leads to a very similar screening procedure. This further
illustrates the ﬂexibility and wide applicability of our proposed screening strategy.
Note that conditional on Xi and Xk, F0(˜ Yi | XT
i β0) and F0(˜ Yk | XT
kβ0) are independent
and identically distributed uniform random variables. Therefore, we know that
P
 
F0(˜ Yi | X
T
i β0) < F0(˜ Yk | X
T
kβ0)
 
= (3.8)
E
 
P
 
F0(˜ Yi | X
T
i β0) < F0(˜ Yk | X
T
kβ0) | Xi,Xk
  
=
1
2
. (3.9)
This fact can be used to construct the marginal estimating equations. Consider
U(β) = n
−2
n  
k=1
n  
i=1
Xi
 
I{F0(˜ Yi | X
T
i β) < F0(˜ Yk | X
T
kβ)} −
1
2
 
. (3.10)
Since E{U(β0)} = 0, (3.10) is an unbiased estimating equation for β0. Furthermore, it is a
U-statistic of order m = 2, which is covered by the framework of Section 3.2.3.
It is important to note that (3.10) cannot be implemented in practice, because the func-
tional form of F0(y | XTβ) is unknown, yet it is still useful for constructing a screening
72procedure. Recall that EEScreen uses the statistic U(0), and for (3.10),
U(0) = n
−2
n  
k=1
n  
i=1
Xi
 
I{F0(˜ Yi | X
T
i 0) < F0(˜ Yk | X
T
k0)} −
1
2
 
(3.11)
= n
−2
n  
k=1
n  
i=1
Xi
 
I(˜ Yi < ˜ Yk) −
1
2
 
, (3.12)
because F0(y | XT
i 0) = F0(y | XT
k0) = F0(y | 0), which is a monotonic function since F0 is
a distribution function. Under the marginal model that β0j′ is the only non-zero parameter,
the jth component of E{U(0)} is cor{Xij,F(˜ Yi | Xij′)}. Thus the j′th component of U(0)
gives the most powerful score test, so EEScreen with (3.10) retains parameters
 
j :
         
n
−2
n  
k=1
n  
i=1
Xij
 
I(˜ Yi < ˜ Yk) −
1
2
          
≥ γn
 
, (3.13)
or equivalently,  
j :
         
n
−2
n  
k=1
n  
i=1
XijI(˜ Yi < ˜ Yk)
         
≥ γn
 
, (3.14)
because the Xi are standardized to have mean 0. In the notation of Zhu et al. (2011), this
is equivalent to using |E{Ωj(˜ Yi)}| as the screening statistic for the jth covariate, rather than
E{Ωj(˜ Yi)2}.
The ˜ Yi may not be fully observed in the presence of censoring. If Ci are the censoring
times, let Yi = min(˜ Yi,Ci) and δi = I(˜ Yi ≤ Ci). Then if we assume that the Ci are
independent of the ˜ Yi and Xi, we can see that
E
 
δiI(Yi < Yk)
S2
C(Yi)
       Xi,Xk
 
= E
 
E
 
I(˜ Yi ≤ Ci)I(˜ Yi ≤ Ck)I(˜ Yi ≤ ˜ Yk)
S2
C(˜ Yi)
       
˜ Yi,Xi,Xk
  
(3.15)
= E
 
E
 
S2
C(˜ Yk)I(˜ Yi ≤ ˜ Yk)
S2
C(˜ Yi)
       
˜ Yi,Xi,Xk
  
(3.16)
= E{I(˜ Yk < ˜ Yk) | Xi,Xk}, (3.17)
where SC is the survival function of the Ci. If the support of the Ci is less than that of the
˜ Yi, the SC(Yi) term above could equal 0 for some Yi. Thus this method of accommodating
censoring could cause diﬃculty if it were used in the estimating equation (3.10) and could
73lead to inconsistent estimation of β0 (Fine et al., 1998). For simplicity, we will assume here
that the support of Ci is greater than or equal to that of ˜ Yi.
This then suggests that in the presence of censoring, the screening statistic of Zhu et al.
(2011) should become
n
−1
n  
k=1
 
n
−1
n  
i=1
Xij
δiI(Yi < Yk)
ˆ S2
C(Yi)
 2
, (3.18)
and the screening statistic derived using EEScreen should become
         
n
−2
n  
k=1
n  
i=1
Xij
δiI(Yi < Yk)
ˆ S2
C(Yi)
         
, (3.19)
where ˆ SC is the Kaplan-Meier estimate of SC. This illustrates that the EEScreen framework
is ﬂexible enough to allow us to derive something similar to the approach of Zhu et al.
(2011), which was originally motivated by very diﬀerent considerations. It also suggests that
EEScreen can provide a sensible screening procedure for a particular model, such as the
single-index model, even if the associated estimating equation (3.10) is not implementable
in practice.
3.4 iEEScreen
Though the simplicity of EEScreen and related screening procedures is appealing, if the
covariates are highly correlated, then in ﬁnite samples these univariate screening methods
may not be able to achieve sure screening without incurring a large number of false positives.
To address this issue, Fan and Lv (2008) and Fan et al. (2009) proposed iterative screening,
where the general idea is as follows. Below, Ml and Al denote sets of covariate indices. In
other words, Ml,Al ⊆ {1,...,pn}.
1. Set M0 to be the empty set.
2. For l = 1 : L,
74(a) controlling for the variables in Ml−1, screen the remaining covariates
(b) select a set Al of the most important of these covariates
(c) use a multivariate variable selection method, such as lasso or SCAD, on the co-
variates in Ml−1 ∪ Al to get a reduced set Ml
We can adapt these ideas to develop an iterative version of EEScreen, which we will
call iEEScreen. However, to operationalize iEEScreen and iterative screening algorithms in
general, we must ﬁrst specify a number of parameters, such as how large |Al| and |Ml| should
be, what multivariate variable selection procedure to use, and how many iterations to run.
Fan et al. (2011) recommended choosing the Al using a permutation-based procedure, and
the Ml using a SCAD-type variable selector (Fan and Li, 2001) with cross-validation. Their
iterations stop when either |Ml| > |A1|, or Ml = Ml−1. These are sensible choices, but the
many diﬀerent layers of this procedure make it diﬃcult to analyze.
Instead, here we will show that the EEBoost method of Wolfson (2011), viewed as a
variable selector rather than an estimation procedure, can actually be thought of as a version
of iEEScreen. By linking iterative screening and boosting, we embed iEEScreen in the
theoretical framework already developed for EEBoost and other boosting methods. In the
future, this theoretical framework could in turn be applied to analyze the properties of
iterative screening.
We ﬁrst brieﬂy describe the EEBoost algorithm (Wolfson, 2011). For some small ǫ > 0
and the full estimating equation U,
1. Set β
(0) = 0.
2. For t = 1 : T,
(a) compute ∆ = |U(β
(t−1))|
(b) identify jt = argmaxj ∆j, where ∆j is the jth component of ∆
75(c) set β
(t)
jt = β
(t−1)
jt − ǫ   sign(∆jt), where β
(t)
jt is the jth
t component of β
(t)
Here, T serves as the regularization parameter, and for a given T only a certain number
of β
(t)
jt will have been updated from their initial values of zero, eﬀecting variable selection.
Wolfson (2011) recommends choosing ǫ in the range [0.001,0.05], and T can be chosen with
some tuning procedure.
To express EEBoost as an iterative version of EEScreen, note that at the beginning of
EEBoost, ∆j corresponds to the screening statistic |Uj(0)| used in EEScreen. Evaluating U
at subsequent β
(t−1) is a way of controlling for the variables that have already been selected
into the model by EEBoost, which is step 2(a) of iterative screening. In particular, for
i = 0,1,... deﬁne ti such that  β
(ti) 0  =  β
(ti+1) 0. In other words, t0 is the ﬁrst time
that the number of nonzero components of β
(t) changes, t1 is the second time this happens,
and so on. Then looking back at the iterative screening algorithm, for l = 1,...,L we can
identify Ml−1 to be {j : β
(tl−1)
j  = 0}, Al to be {jtl}, and Ml as being obtained by running
EEBoost for tl iterations starting from the covariates in Mtl−1 ∪ Al. We can choose L by
tuning EEBoost with a generalized cross-validation-type criterion. We will thus implement
iEEScreen using the EEBoost algorithm.
In the remainder of this paper we study the eﬀects of using EEScreen and iEEScreen as
preprocessing steps before ﬁtting regularized regression models. In particular, we will use
EEBoost to ﬁt the regressions, for two reasons. First, we would like to compare the eﬀects
of retaining diﬀerent numbers of covariates after screening, from keeping only one or two
covariates to keeping tens of thousands. Therefore we require a regularization method for
estimating equations that can handle an arbitrarily large number of covariates. Second, in
Section 3.5.2 we study a discrete estimating equation, so we require a regularization method
which works well in that situation. To our knowledge, EEBoost is the only procedure that
meets both of these criteria.
76However, this leads to a unique problem. We would naturally like to compare the eﬀects
of using EEScreen versus iEEScreen. But a careful inspection of the EEBoost algorithm
reveals that running EEBoost twice, in other words ﬁrst selecting covariates using EEBoost,
and then using only those covariates in another instance of EEBoost, is actually identical to
using EEBoost only once. This means that screening with the version of iEEScreen described
in this section has no eﬀect if EEBoost is then used for model-ﬁtting. This behavior is
diﬀerent from, say, the lasso, where running two iterations of the lasso has been termed
the relaxed lasso (Meinshausen, 2007) and can give diﬀerent results from the regular lasso.
Therefore while we will be able to compare the variable selection properties of EEScreen
and iEEScreen in simulations, where we will know the true model, we will not be able to
compare EEScreen+EEBoost versus iEEScreen+EEBoost. We would like to address this
issue in future work.
3.5 Simulations
In our simulation studies, we evaluated the performances of EEScreen and iEEScreen with
two diﬀerent estimating equations, one for a t-year survival model and the other for an
accelerated failure time model. We implemented iEEScreen by using EEBoost, as described
in Section 3.4, with ǫ = 0.01. We compared these to the naive approach of ﬁtting pn marginal
regressions, as well as to the method of Zhu et al. (2011) and our EEScreen-derived method
(3.19) from Section 3.3.
We studied pn = 20000 covariates and set the true parameter vector β0 to be such that
β0j = 1.5,j = 1,...,10, β0j = −0.8,j = 11,...,20, and β0j = 0,j = 21,...,pn. We
generated covariates Xi from a pn-dimensional zero-mean multivariate normal. To simulate
an easy setting we used a covariance matrix that satisﬁed the partial orthogonality condition
of Fan and Song (2010), where the important covariates were independent of the unimportant
covariates. The covariance matrix consisted of 9 blocks of 10 covariates, 1 block of 910
77covariates, and 19 blocks of 1000 covariates. Each block had a compound symmetry structure
with the same correlation parameter ρ, which was equal to either 0.5 or 0.9, and the blocks
were independent from each other. We matched the non-zero components of β0 with two of
the 10-dimensional blocks. To simulate a more diﬃcult setting we let the entire covariance
matrix have a compound symmetry structure with ρ equal to either 0.3 or 0.5.
3.5.1 The t-year survival model
We ﬁrst considered a t-year survival model. Let Ti and Xi be the survival time and the
covariate vector of the ith patient, respectively. We modeled the probability of surviving
beyond some time t0 conditional on covariates as
logit{P(Ti ≥ t0 | Xi)} = X
T
i β0. (3.20)
This model is very useful in clinical investigations, and in fact we apply it to data from
clinical trials of multiple myeloma therapies in Section 3.6.
However, we cannot use the logistic regression because the Ti are not directly observed.
Let Ci be the censoring time, such that we only observe Yi = min(Ti,Ci) and δi = I(Ti ≤ Ci).
Without modeling the Ci, it is diﬃcult to specify a full likelihood model for this data, so we
instead turn to estimating equations. To account for the censored data, Jung (1996) assumed
that the Ci were independent of the Ti and the Xi and proposed using the estimating equation
U(β) = n
−1
n  
i=1
Xiπ′(XT
i β)
π(XT
i β){1 − π(XT
i β)}
 
I(Yi ≥ t0)
ˆ SC(t0)
− π(X
T
i β)
 
, (3.21)
where π(η) = logit
−1(η), π′(η) = ∂π/∂η, and ˆ SC(t) is the Kaplan-Meier estimate of the
survival function of the Ci. According to our procedure, after some simpliﬁcation we see
that EEScreen will retain the parameters
 
j :
         
n  
i=1
Xij
I(Yi ≥ t0)
ˆ SC(t0)
         
≥ γn
 
(3.22)
78Table 3.1: Median minimum model size (interquartile range) for the t-year survival model
Partial orthogonality Compound symmetry
ρ = 0.5 ρ = 0.9 ρ = 0.3 ρ = 0.5
EEScreen 2849 (6180) 22 (249.5) 19666.5 (610.5) 19676 (559.5)
Marginal 2908 (6278) 22 (228.75) 19659 (611.5) 19696 (550.5)
Zhu et al. (2011) 9614.5 (9497.75) 2043.5 (7687) 19647.5 (655.5) 19531.5 (737)
Method (3.19) 7559.5 (11737.75) 944.5 (4121.25) 19614.5 (716.75) 19545.5 (726.5)
Though Uj does not satisfy Assumption 13 because of the ˆ SC(t) term, Jung (1996) showed
that it can be written in the appropriate form, plus a negligible oP(1) term. To ﬁt the pn
regressions for the marginal screening method we used a simple Newton-Raphson procedure
to solve Uj.
Tuning EEBoost and iEEScreen was diﬃcult because commonly used criteria such as
AIC or BIC are not deﬁned in the absence of a likelihood. We instead chose to minimize the
GCV-type criterion   BS/(1 − n−1 ˆ β 0)2, where  ˆ β 0 is the number of nonzero components
of ˆ β, and   BS is the estimate of the Brier score at t0. If ˆ π(t0 | Xi) is the predicted survival
probability of patient i at t0, then   BS is deﬁned by Graf et al. (1999) as
  BS = n
−1  
i
 
{0 − ˆ π(t0 | Xi)}2
ˆ SC(Xi)
I(Yi ≤ t0,δi = 1) +
{1 − ˆ π(t0 | Xi)}2
ˆ SC(t0)
I(Yi ≥ t0)
 
. (3.23)
We generated survival times for n = 100 subjects from log(Ti) = XT
i β0 + εi with εi
having a logistic distribution with mean -0.5 and scale 1. Under this scheme the model of
Jung (1996) is correctly speciﬁed. We generated Ci from an exponential distribution to give
approximately 50% censoring. We observed that the 20th percentile of the simulated survival
times was roughly t0 = 0.005, so we used this t0 when implementing the estimating equation.
We simulated 200 such datasets.
Table 3.1 reports the median sizes of the smallest models ˆ M found by the diﬀerent
screening methods that still contained the true model M. The performance is best under the
partial orthogonality setting when ρ = 0.9, which is not surprising because this setting leads
79Table 3.2: Average runtime in seconds (standard deviation) for the t-year survival model
Partial orthogonality Compound symmetry
ρ = 0.5 ρ = 0.9 ρ = 0.3 ρ = 0.5
EEScreen 1.29 (0.09) 1.38 (0.47) 1.38 (0.36) 1.32 (0.16)
Marginal 617.79 (61.99) 1023.79 (1405.58) 1608.09 (2594.27) 1054.86 (252.32)
Zhu et al. (2011) 1.52 (0.08) 1.58 (0.45) 1.88 (4.47) 1.49 (0.2)
Method (3.19) 1.54 (0.09) 1.58 (0.45) 2.13 (8.02) 1.48 (0.18)
to the greatest separation between the important and unimportant covariates. EEScreen and
marginal screening show similar performances, while our method (3.19) appears to actually
outperform the method of Zhu et al. (2011) in the partial orthogonality setting.
Though EEScreen and marginal screening produce similar results, Table 3.2 shows that
marginal screening, at least for this t-year survival model, can take much longer. These
simulations were run on the Orchestra cluster supported by the Harvard Medical School
Research Information Technology Group, on machines with 3.6 GHz Intel Xeon processors
with at least 12GB of memory, and marginal screening took at least 10 minutes. On the
other hand, the EEScreen-type methods and the method of Zhu et al. (2011) were completed
in a few seconds, showing the EEScreen can be much more computationally eﬃcient than
standard screening methods.
To better understand the performances of these various screening methods, we studied
in Figure 3.1 the average number of false positives corresponding to a given number of false
negatives achieved by the screened model ˆ M. We again see that the methods perform best
in the partial orthogonality setting when the correlation is high. Furthermore, given the
same setting, EEScreen performs better than the model-free methods. This is most likely
because the model used by EEScreen is correctly speciﬁed, and thus should be more powerful
than the model-free methods. This type of phenomenon was also pointed out by Zhu et al.
(2011). As in Table 3.1, our method (3.19) again appears to outperform that of Zhu et al.
(2011).
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Figure 3.1: Screening performances for the t-year survival model
Figure 3.1 also shows that in all cases, the variable selection performance of iEEScreen far
outperforms the other methods, particularly in the compound symmetry setting. However,
we found that iEEScreen is not able to include all of the important covariates. In the partial
orthogonality setting, it can only include up to 17 or 18 of the important covariates, while in
the compound symmetry setting it cannot achieve fewer than 15 false negatives. It turns out
that the boosting procedure we use to implement iEEScreen saturates at some point in its
ﬁtting, perhaps due to the fact that there are more parameters than covariates, or perhaps
because our choice for the boosting parameter ǫ = 0.01 might be too large.
Next we studied the eﬀect on estimation accuracy of using screening before ﬁtting a
regularized regression model with EEBoost. Figure 3.2 reports the average mean squared
error of estimation (MSE) as a function of | ˆ M|, the number of variables kept after screening.
Here we deﬁned MSE as  ˆ β − β0 2
2, where ˆ β is the estimate obtained by EEBoost after
screening. It is clear that using EEScreen ﬁrst can improve the estimation accuracy of
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Figure 3.2: Mean squared errors for the t-year survival model
EEBoost, especially in the compound symmetry setting. Screening with the model-free
methods does not appear to reduce the MSE, perhaps because they need to retain a large
number of covariates before they include the important variables (Table 3.1).
On the other hand, estimation error is not so meaningful in the absence of a correctly
speciﬁed model. We therefore considered the out-of-sample predictive ability, as measured by
the AUC statistic (Uno et al., 2007) at time t0, of the models ﬁt by EEBoost after screening
in Figure 3.3. In the partial orthogonality settings, using EEScreen ﬁrst does not appear
to have much of an eﬀect on the AUC, while in the compound symmetry setting it does
improve the predictive ability of the subsequent ﬁtted model. Our model-free method (3.19)
does not seem to have much of an eﬀect on AUC in either setting, but appears to perform
slightly better than the method of Zhu et al. (2011).
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Figure 3.3: Out-of-sample AUCs for the t-year survival model
3.5.2 The accelerated failure time model
The t-year survival model is useful when we are interested in a ﬁxed event time. To study
the entire survival distribution, one useful approach is the accelerated failure time (AFT)
model, which posits that
log(Ti) = X
T
i β0 + εi, (3.24)
where the εi are independent and identically distributed, and the εi can have an arbitrary
distribution. The β can be estimated using the U-statistic-based estimating equation
U(β) = n
−2
n  
i=1
n  
k=1
(Xk − Xi)I{ei(β) ≤ ek(β)}δi, (3.25)
where ei(β) = log(Yi)−XT
i β (Tsiatis, 1996; Jin et al., 2003; Cai et al., 2009). Following our
procedure, after some simpliﬁcation we see that EEScreen will retain the parameters
 
j :
         
n  
i=1
n  
k=1
(Xkj − Xij)I(Yi ≤ Yk)δi
         
≥ γn
 
. (3.26)
83Table 3.3: Median minimum model size (interquartile range) for the AFT model
Partial orthogonality Compound symmetry
ρ = 0.5 ρ = 0.9 ρ = 0.3 ρ = 0.5
EEScreen 997 (2968.75) 20 (2) 19829.5 (316.25) 19822.5 (401.25)
Marginal 1750.5 (3742.25) 21 (144) 19835 (353) 19764 (436)
Zhu et al. (2011) 10761.5 (9416) 747 (3804.5) 19482 (854) 19464.5 (922.5)
Method (3.19) 7940.5 (11962.75) 282.5 (2230.5) 19501.5 (800.25) 19522 (785.75)
This is a U-statistic of order m = 2 and therefore satisﬁes our assumptions in Section 3.2.3.
Despite being a discrete estimating equation, (3.25) poses no additional problems to EE-
Screen or iEEScreen. To ﬁt the pn regressions for the marginal screening method we used
the method of Jin et al. (2003), available in the R package lss.
To tune EEBoost and iEEScreen, consider the function
L(β) = n
−2
n  
i=1
n  
j=1
{ej(β) − ei(β)}I{ei(β) ≤ ej(β)}δi. (3.27)
Cai et al. (2009), in their work on regularized estimation for the AFT model, argued that
L(β) is an adequate measure of the accuracy of estimation. They and Jin et al. (2003) also
noted that U(β) is the “quasiderivative” of −L(β). For these reasons, we tuned EEBoost
by minimizing the GCV-type criterion
L(ˆ β)/(1 − n
−1 ˆ β 0)
2, (3.28)
where we used L(β) in place of a negative log-likelihood.
We generated n = 100 survival times from log(Ti) = XT
i β0+εi with εi having a standard
normal distribution. We generated Ci independently from an exponential distribution to
give approximately 50% censoring, and we simulated 200 datasets.
We report for the diﬀerent screening methods the smallest ˆ M that still contained M
in Table 3.3. As with the t-year survival model, the methods perform best in the partial
orthogonality setting with ρ = 0.9. We also again see that our method (3.19) outperforms
84Table 3.4: Average runtime in seconds (standard deviation) for the AFT model
Partial orthogonality Compound symmetry
ρ = 0.5 ρ = 0.9 ρ = 0.3 ρ = 0.5
EEScreen 1.58 (0.15) 1.53 (0.1) 1.51 (0.1) 1.51 (0.11)
Marginal 1024.71 (114.2) 971.85 (82.5) 1081.56 (149.64) 1203.19 (106.81)
Zhu et al. (2011) 1.6 (0.16) 1.46 (0.11) 1.44 (0.1) 1.46 (0.11)
Method (3.19) 1.6 (0.15) 1.46 (0.11) 1.44 (0.09) 1.45 (0.11)
the method of Zhu et al. (2011). In addition, Table 3.4 shows that marginal screening is
much more time-consuming than the EEScreen-based methods or the procedure of Zhu et al.
(2011).
Figure 3.4 reports the average number of false positives contained in ˆ M as the number
of allowed false negatives is varied. As in the t-year survival model simulations, iEEScreen
performs better than non-iterative EEScreen, though in the compound symmetry case it
also saturates before it can select all of the important covariates. We also see that the
EEScreen outperforms the model-free methods again, and that our method (3.19) somewhat
outperforms the method of Zhu et al. (2011). The plots in Figure 3.4 for the model-free
methods look very similar to the corresponding ones in Figure 3.1, and this is because the
models used to generate both survival times were both AFT models, diﬀering only in the
distributions of the error terms.
The average mean square errors of the models ﬁt after screening are plotted in Figure 3.5.
Similar to the results for the t-year survival model, we see that screening using model-free
methods does not improve the estimation accuracy of the subsequent regularized regression
ﬁt. Interestingly, for the AFT model it appears that screening with EEScreen only barely
decreases the MSE under partial orthogonality, and is actually detrimental to the MSE in
the compound symmetry setting, in contrast to the results for the t-year survival model.
We see something similar when we examine the out-of-sample predictive abilities of the
models ﬁt by EEBoost after screening. We calculated the C-statistics (Uno et al., 2011a)
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Figure 3.4: Screening performances for the AFT model
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Figure 3.5: Mean squared errors for the AFT model
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Figure 3.6: Out-of-sample C-statistics for the AFT model
of the ﬁtted models on independently generated datasets and report them in Figure 3.6.
EEScreen does not have much of an eﬀect on the C-statistic, while using the model-free
methods tend to decrease the predictive ability of the ﬁtted model.
The results in Figures 3.5 and 3.6 are in contrast to the corresponding t-year survival
simulation results, which showed the EEScreen can indeed improve MSE and prediction.
This may be due to the way these ﬁgures were generated: to plot these ﬁgures we varied
the size of ˆ M from between 400 to 20000 in increments of 400. However, the advantages
of screening in the AFT setting perhaps may only be seen if fewer than 400 covariates are
retained.
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Figure 3.7: Kaplan-Meier estimates from multiple myeloma clinical trials
3.6 Data example
We illustrate our methods on data from a multiple myeloma clinical trial. Multiple myeloma
is the second-most common hematological cancer, but despite recent advances in therapy
the sickest patients have seen little improvement in their prognoses. It is of great interest
to explore whether genomic data can be used to predict which patients will fall into this
high-risk subgroup, so that they might be targeted for more aggressive or experimental
therapies.
The MicroArray Quality Control Consortium II (MAQC-II) study posed exactly this
question to 36 teams of analysts representing academic, government, and industrial insti-
tutions (Shi et al., 2010). It used data from newly diagnosed multiple myeloma patients
who were recruited into clinical trials UARK 98-026 and UARK 2003-33, which studied the
treatment regimes total therapy II (TT2) and total therapy III (TT3), respectively (Zhan
et al., 2006; Shaughnessy et al., 2007). Teams were asked to predict the probability of sur-
viving past t0 = 24 months, which is roughly the median survival time of high-risk myeloma
patients (Kyle and Rajkumar, 2008), using the TT2 arm as the training set and the TT3
arm as the testing set.
88Table 3.5: AUCs for probability of surviving past t0 = 24 months
Method Optimal | ˆ M| 5-fold CV AUC (SD) AUC in TT3
EEScreen (t-year) 5000 0.61 (0.03) 0.61
Method (3.19) 10 0.63 (0.06) 0.58
Zhu et al. (2011) 100 0.67 (0.08) 0.59
EEScreen (AFT) 100 0.65 (0.08) 0.70
There were 340 patients in TT2, with 126 events and an average follow-up time of 55.82
months, and 214 patients in TT3, with 43 events and an average follow-up of 37.03 months.
The Kaplan-Meier estimates of the survival curves are given in Figure 3.7. Gene expression
values for 54675 probesets were measured for each subject using Aﬀymetrix U133Plus2.0
microarrays, and 13 clinical variables were also recorded, including age, gender, race, and
serum β2-microglobulin and albumin levels.
Figure 3.7 shows that there was a patient in TT2 censored before 24 months, so we
cannot model these data using simple logistic regression. We therefore considered the t-
year survival model with estimating equation (3.21), from Section 3.5.1. Because we had
a total of 54688 covariates and only 340 patients in TT2, we ﬁrst implemented a screening
step, where we considered EEScreen, our model-free method (3.19), and the method of Zhu
et al. (2011). We then ﬁt the screened variables using EEBoost, with the generalized cross-
validation criterion described in Section 3.5.1. To choose the size of ˆ M, we used 5-fold
cross-validation and selected the value of | ˆ M| that gave the best average AUC statistic. The
values we considered were 10, 50, 100, 500, 1000, and the numbers from 5000 to 54688 in
increments of 5000. Finally, we validated our model in the TT3 arm.
Table 3.5 summarizes our results. We ﬁrst focused on the AUCs estimated using ﬁve-fold
cross-validation. Surprisingly, we found that EEScreen gave us the lowest AUC, and that the
model-free methods required fewer covariates while giving better prediction. However, note
that screening using the t-year survival estimating equation (3.21) essentially dichotomizes
the observed times to binary outcomes, because we are only modeling whether they are
89larger than t0. In contrast, we can see from the forms of method (3.19) and the procedure
of Zhu et al. (2011) that they use continuous outcomes. We therefore hypothesized that
the model-free methods had more power than EEScreen based on equation (3.21) to detect
covariate eﬀects, even though they did not incorporate any modeling assumptions.
To test this hypothesis we examined the performance of using EEScreen based on the
AFT model estimating equation (3.25). This strategy does not dichotomize the survival
outcomes and is also a more restrictive model than the t-year model because it makes a
global assumption on the distribution of the survival times. After screening we still used the
t-year survival model to ﬁt the retained covariates. Indeed, Table 3.5 shows that with this
strategy, we needed to retain only 100 covariates to achieve a high AUC.
Turning now to the validation AUCs calculated in the TT3 arm, we found that though
the model-free methods gave higher AUCs in cross-validation, their validation AUCs were
essentially comparable to that of EEScreen based on the t-year survival model. This might
perhaps indicate that the model-free methods actually overﬁt to patients in the TT2 arm,
and thus their results didn’t generalize well to patients treated with TT3. In contrast, the
EEScreen method based on the AFT model gave a much higher validation AUC of 70%.
The ﬁnal ﬁtted model contained 37 covariates, which in addition to various gene expression
levels also included β2-microglobulin, albumin, and lactate dehydrogenase levels. Thus our
method was able to select important clinical predictors in addition to identifying potentially
important genomic factors.
3.7 Discussion
In this paper we introduced EEScreen, a new computationally convenient screening method
that can be used with any estimating equation-based regression method. We proved ﬁnite-
sample performance guarantees that hold for any model that can be ﬁt with U-statistic-based
90estimating equations, and in addition showed that our approach could be used to derive a
model-free screening procedure very similar to one proposed by Zhu et al. (2011). Finally,
we have drawn a connection between screening and boosting methods, showing that the
EEBoost algorithm of Wolfson (2011) can be viewed as a form of iterative screening.
Our simulation results, conducted using a t-year survival model as well as the AFT
model, support the use of EEScreen in practice. They suggest that EEScreen is capable of
retaining most of the important covariates without also including too many false positives,
unless the covariates are very highly correlated. In terms of estimation and prediction, when
the working model is correctly speciﬁed, using EEScreen will usually not give worse results
than not using screening at all, and at the very least will dramatically reduce the required
computation time. This does not always appear to be true of the model-free methods.
On the other hand, in our multiple myeloma example we saw that using diﬀerent models
for the screening step and the regression step can oﬀer better performance than keeping
to one model throughout. This illustrates the diﬃculty in choosing a default screening
procedure that works well in all cases. However, our myeloma results suggest that one key
consideration is the power of the screening step. The AFT model-based screening appeared to
have greater power than the t-year model, and perhaps its modeling assumptions prevented
it from overﬁtting to the TT2 arm, as the model-free methods seemed to do.
This insight implies that diﬀerent situations will require choosing diﬀerent screening
methods in order to achieve the greatest power. Estimating equations give us access to a
wide range of models to choose from, with more parametric models oﬀering lower variance
but higher bias, and models with fewer assumptions oﬀering the opposite tradeoﬀ. Thus our
EEScreen approach is perfectly suited to this screening strategy, oﬀering quick computation
and good theoretical properties for whichever model we decide to use.
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3.8 Appendix A: Proofs
3.8.1 Proof of Theorem 7
The event {M ⊆ ˆ M} equals {minj∈M |Uj(0)| ≥ γn}, so it is easy to see that
P(M ⊆ ˆ M) ≥ 1 −
 
j∈M
P(|Uj(0)| < γn). (3.29)
By the triangle inequality, we know that for all j, |uj(0)| ≤ |Uj(0)−uj(0)|+|Uj(0)|, and by
Assumption 15 we see that c1[n/m]−κ − |Uj(0)| ≤ |Uj(0) − uj(0)| for all j ∈ M. Therefore,
|Uj(0)| < γn for j ∈ M implies |Uj(0) − uj(0)| ≥ c1[n/m]1−κ/2. We can conclude from
Assumptions 13 and 14 and Bernstein’s inequality for U-statistics (Hoeﬀding, 1963) that
P(M ⊆ ˆ M) ≥ 1 − 2sn exp
 
−
c2
1[n/m]1−2κ/4
2Σ2 + bc1[n/m]−κ/3
 
(3.30)
3.8.2 Proof of Theorem 8
For the marginal estimating equations Uj and their expected values uj, we know from As-
sumptions 13 and 14 and Bernstein’s inequality for U-statistics (Hoeﬀding, 1963) that
P{max
j
|Uj(0) − uj(0)| ≤ c1[n/m]
−κ/4} ≥ 1 − 2pn exp
 
−
c2
1[n/m]1−2κ/16
2Σ2 + bc1[n/m]−κ/6
 
. (3.31)
92Also, if maxj |Uj(0) − uj(0)| ≤ c1[n/m]−κ/4, then |Uj(0)| ≥ γn implies that |uj(0)| ≥
c1[n/m]−κ/4. This means that
| ˆ M| = |{j : |Uj(0)| ≥ γn}| ≤ |{j : |uj(0)| ≥ c1[n/m]
−κ/4}| ≤
16
c2
1[n/m]−2κ
 
j
uj(0)
2. (3.32)
From our EEScreen procedure described in Section 3.2.1, we see that the uj(0) are
the possibly relabeled components of the expected full estimating equation u(0). Thus
 
j uj(0)2 =  u(0) 2
2, and by the generalization of the mean value theorem to vector-valued
functions (Hall and Newell, 1979) and Assumptions 17 and 16,
 u(0) 2 =  u(β0)−u(0) 2 ≤ sup
0<t<1
 i(tβ0) 2 β0 2 ≤ c2 sup
0<t<1
σmax{i(tβ0)} = c2σ
∗
max, (3.33)
so that
P
 
| ˆ M| ≤
16c2
2σ∗2
max
c2
1[n/m]−2κ
 
≥ P{max
j
 Uj(0) − uj(0) ∞ ≤ c1[n/m]
−κ/4} (3.34)
≥ 1 − 2pn exp
 
−
c2
1[n/m]1−2κ/16
2Σ2 + bc1[n/m]−κ/6
 
. (3.35)
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